<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40869289</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>16</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>18</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7968</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms26167968</ELocationID><Abstract><AbstractText>Ulcerative colitis is a chronic inflammatory bowel disease characterized by persistent inflammation, immune dysregulation, gut microbiota alterations, and impaired epithelial barrier function. <i>Lupinus albus</i> is a legume rich in galactooligosaccharides (GOS) that functions as a prebiotic capable of modulating the gut microbiota and mitigating ulcerative colitis-related damage. This study aimed to elucidate the effect of GOS on gut microbiota modulation and the molecular mechanisms involved in epithelial restoration and inflammation reduction. Fifteen C57BL/6 mice were randomly assigned to three groups (<i>n</i> = 5 per group): control (CTL), ulcerative colitis (UC), and ulcerative colitis + GOS (UC + GOS). UC was induced by administering 2% dextran sulfate sodium (DSS) in drinking water for seven days. The UC + GOS group received 2.5 g/kg BW of GOS via gavage for 14 days. GOS administration improved mucus layer thickness, regulated the expression of tight junction proteins, reduced pro-inflammatory cytokine levels, and modulated the gut microbiota, preventing the loss of richness and diversity. Additionally, the expression of monocarboxylate transporters (MCTs) MCT1 and MCT4 was evaluated, and significant differences were observed between the groups across colon and cecum tissues. These findings suggest that GOS supplementation may play a potential role in attenuating ulcerative colitis by regulating the gut microbiota and the metabolic state of intestinal cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>God&#xed;nez-M&#xe9;ndez</LastName><ForeName>Lucila A</ForeName><Initials>LA</Initials><Identifier Source="ORCID">0000-0002-1631-2370</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Inmunolog&#xed;a y Dermatolog&#xed;a (CIINDE), Departamento de Fisiolog&#xed;a, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento Acad&#xe9;mico de Ciencias B&#xe1;sicas, Universidad Aut&#xf3;noma de Guadalajara, Av. Patria 120, Zapopan 45129, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vega-Maga&#xf1;a</LastName><ForeName>Alejandra Natali</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0003-4749-2498</Identifier><AffiliationInfo><Affiliation>Laboratorio de Diagn&#xf3;stico en Enfermedades Emergentes y Reemergentes (LADEER), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n en C&#xe1;ncer e Infecciones (LICI), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-Rodr&#xed;guez</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3016-4295</Identifier><AffiliationInfo><Affiliation>Laboratorio de Diagn&#xf3;stico en Enfermedades Emergentes y Reemergentes (LADEER), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n en C&#xe1;ncer e Infecciones (LICI), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valencia-Hern&#xe1;ndez</LastName><ForeName>Gisela Anay</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Inmunolog&#xed;a y Dermatolog&#xed;a (CIINDE), Departamento de Fisiolog&#xed;a, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-S&#xe1;nchez</LastName><ForeName>Germ&#xe1;n</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5573-3648</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Inmunolog&#xed;a y Dermatolog&#xed;a (CIINDE), Departamento de Fisiolog&#xed;a, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>I&#xf1;iguez-Guti&#xe9;rrez</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Departamento Acad&#xe9;mico de Ciencias B&#xe1;sicas, Universidad Aut&#xf3;noma de Guadalajara, Av. Patria 120, Zapopan 45129, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Roa</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2339-4108</Identifier><AffiliationInfo><Affiliation>Laboratorio de Investigaci&#xf3;n y Desarrollo Farmac&#xe9;utico (LIDF), Departamento de Farmacobiolog&#xed;a, Centro Universitario de Ciencias Exactas e Ingenier&#xed;as, Universidad de Guadalajara, Guadalajara 44430, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramos-M&#xe1;rquez</LastName><ForeName>Martha Eloisa</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0003-4064-5578</Identifier><AffiliationInfo><Affiliation>Departamento de Biolog&#xed;a Molecular y Gen&#xf3;mica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fafutis-Morris</LastName><ForeName>Mary</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5384-1175</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Inmunolog&#xed;a y Dermatolog&#xed;a (CIINDE), Departamento de Fisiolog&#xed;a, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delgado-Rizo</LastName><ForeName>Vidal</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Inmunolog&#xed;a y Dermatolog&#xed;a (CIINDE), Departamento de Fisiolog&#xed;a, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009844">Oligosaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>9042-14-2</RegistryNumber><NameOfSubstance UI="D016264">Dextran Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009844" MajorTopicYN="Y">Oligosaccharides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016264" MajorTopicYN="N">Dextran Sulfate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007413" MajorTopicYN="N">Intestinal Mucosa</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="Y">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003092" MajorTopicYN="Y">Colitis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="N">Prebiotics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lupinus</Keyword><Keyword MajorTopicYN="N">MCT1</Keyword><Keyword MajorTopicYN="N">MCT4</Keyword><Keyword MajorTopicYN="N">galactooligosaccharides</Keyword><Keyword MajorTopicYN="N">microbiota</Keyword><Keyword MajorTopicYN="N">ulcerative colitis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40869289</ArticleId><ArticleId IdType="pmc">PMC12386736</ArticleId><ArticleId IdType="doi">10.3390/ijms26167968</ArticleId><ArticleId IdType="pii">ijms26167968</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choi Y.-S., Kim J.-K., Kim W.-J. Clinical characteristics and prognosis of patients with ulcerative colitis that shows rectal sparing at initial diagnosis. World J. Gastrointest. Endosc. 2021;13:407&#x2013;415. doi: 10.4253/wjge.v13.i9.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.4253/wjge.v13.i9.407</ArticleId><ArticleId IdType="pmc">PMC8474694</ArticleId><ArticleId IdType="pubmed">34630890</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Berre C., Honap S., Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571&#x2013;584. doi: 10.1016/S0140-6736(23)00966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00966-2</ArticleId><ArticleId IdType="pubmed">37573077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T., Siegmund B., Le Berre C., Wei S.C., Ferrante M., Shen B., Bernstein C.N., Danese S., Peyrin-Biroulet L., Hibi T. Ulcerative colitis. Nat. Rev. Dis. Primer. 2020;6:74. doi: 10.1038/s41572-020-0205-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0205-x</ArticleId><ArticleId IdType="pubmed">32913180</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang J., Wang H., Zhou Y., Zhang H., Zhou H., Zhang X. Slimy partners: The mucus barrier and gut microbiome in ulcerative colitis. Exp. Mol. Med. 2021;53:772&#x2013;787. doi: 10.1038/s12276-021-00617-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00617-8</ArticleId><ArticleId IdType="pmc">PMC8178360</ArticleId><ArticleId IdType="pubmed">34002011</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C., Chai Z., Chen S., Zhang H., Zhang X., Zhou Y. Intestinal mucus components and secretion mechanisms: What we do and do not know. Exp. Mol. Med. 2023;55:681&#x2013;691. doi: 10.1038/s12276-023-00960-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-023-00960-y</ArticleId><ArticleId IdType="pmc">PMC10167328</ArticleId><ArticleId IdType="pubmed">37009791</ArticleId></ArticleIdList></Reference><Reference><Citation>Okumura R., Takeda K. The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation. Semin. Immunopathol. 2025;47:2. doi: 10.1007/s00281-024-01026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-024-01026-5</ArticleId><ArticleId IdType="pmc">PMC11599372</ArticleId><ArticleId IdType="pubmed">39589551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakase H., Sato N., Mizuno N., Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun. Rev. 2022;21:103017. doi: 10.1016/j.autrev.2021.103017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.103017</ArticleId><ArticleId IdType="pubmed">34902606</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;u&#x17e;i&#x107; S., Antoli&#x107; M., Ognjenovi&#x107; A., Stupin-Polan&#x10d;ec D., Petrini&#x107; Grba A., Hrva&#x10d;i&#x107; B., Dominis Kramari&#x107; M., Musladin S., Po&#x17e;gaj L., Zlatar I., et al. Claudins: Beyond Tight Junctions in Human IBD and Murine Models. Front. Pharmacol. 2021;12:682614. doi: 10.3389/fphar.2021.682614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.682614</ArticleId><ArticleId IdType="pmc">PMC8635807</ArticleId><ArticleId IdType="pubmed">34867313</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakai D., Miyake M. Intestinal Membrane Function in Inflammatory Bowel Disease. Pharmaceutics. 2024;16:29. doi: 10.3390/pharmaceutics16010029.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics16010029</ArticleId><ArticleId IdType="pmc">PMC10820082</ArticleId><ArticleId IdType="pubmed">38258040</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Boerner K., Muraleedharan C.K., Nusrat A., Quiros M., Parkos C.A. Epithelial JAM-A is fundamental for intestinal wound repair in vivo. JCI Insight. 2022;7:e158934. doi: 10.1172/jci.insight.158934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158934</ArticleId><ArticleId IdType="pmc">PMC9536273</ArticleId><ArticleId IdType="pubmed">35943805</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarpellini E., Ianiro G., Attili F., Bassanelli C., De Santis A., Gasbarrini A. The human gut microbiota and virome: Potential therapeutic implications. Dig. Liver Dis. 2015;47:1007&#x2013;1012. doi: 10.1016/j.dld.2015.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2015.07.008</ArticleId><ArticleId IdType="pmc">PMC7185617</ArticleId><ArticleId IdType="pubmed">26257129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou K., Wu Z.-X., Chen X.-Y., Wang J.-Q., Zhang D., Xiao C., Zhu D., Koya J.B., Wei L., Li J., et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 2022;7:135. doi: 10.1038/s41392-022-00974-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00974-4</ArticleId><ArticleId IdType="pmc">PMC9034083</ArticleId><ArticleId IdType="pubmed">35461318</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15a;wirkosz G., Szczygie&#x142; A., Logo&#x144; K., Wrze&#x15b;niewska M., Gomu&#x142;ka K. The Role of the Microbiome in the Pathogenesis and Treatment of Ulcerative Colitis&#x2014;A Literature Review. Biomedicines. 2023;11:3144. doi: 10.3390/biomedicines11123144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11123144</ArticleId><ArticleId IdType="pmc">PMC10740415</ArticleId><ArticleId IdType="pubmed">38137365</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolfi C., Maresca C., Monteleone G., Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines. 2022;10:289. doi: 10.3390/biomedicines10020289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10020289</ArticleId><ArticleId IdType="pmc">PMC8869546</ArticleId><ArticleId IdType="pubmed">35203499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Liu F., Xue J., Lee S.A., Liu L., Riordan S.M. Bacterial Species Associated with Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms. Front. Microbiol. 2022;13:801892. doi: 10.3389/fmicb.2022.801892.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.801892</ArticleId><ArticleId IdType="pmc">PMC8908260</ArticleId><ArticleId IdType="pubmed">35283816</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., He C., An Y., Huang Y., Zhang H., Fu W., Wang M., Shan Z., Xie J., Yang Y., et al. The Role of Short Chain Fatty Acids in Inflammation and Body Health. Int. J. Mol. Sci. 2024;25:7379. doi: 10.3390/ijms25137379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25137379</ArticleId><ArticleId IdType="pmc">PMC11242198</ArticleId><ArticleId IdType="pubmed">39000498</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Reytor D., Puebla C., Karahanian E., Garc&#xed;a K. Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins. Front. Physiol. 2021;12:650313. doi: 10.3389/fphys.2021.650313.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.650313</ArticleId><ArticleId IdType="pmc">PMC8181404</ArticleId><ArticleId IdType="pubmed">34108884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert D.W., Wood I.S., Ellis A., Shirazi-Beechey S.P. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br. J. Cancer. 2002;86:1262&#x2013;1269. doi: 10.1038/sj.bjc.6600264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6600264</ArticleId><ArticleId IdType="pmc">PMC2375337</ArticleId><ArticleId IdType="pubmed">11953883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Pic&#xf3;n E., Dotti I., Corraliza A.M., Mayorgas A., Esteller M., Perales J.C., Ricart E., Masamunt M.C., Carrasco A., Trist&#xe1;n E., et al. Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients with Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2020;26:43&#x2013;55. doi: 10.1093/ibd/izz119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izz119</ArticleId><ArticleId IdType="pmc">PMC6905302</ArticleId><ArticleId IdType="pubmed">31211831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren K., Yong C., Jin Y., Rong S., Xue K., Cao B., Wei H. Unraveling the microbial mysteries: Gut microbiota&#x2019;s role in ulcerative colitis. Front. Nutr. 2025;12:1519974. doi: 10.3389/fnut.2025.1519974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2025.1519974</ArticleId><ArticleId IdType="pmc">PMC11847676</ArticleId><ArticleId IdType="pubmed">39996003</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Wang H., Yang Z., Zhao K., Li S., He N. The role of functional oligosaccharides as prebiotics in ulcerative colitis. Food Funct. 2022;13:6875&#x2013;6893. doi: 10.1039/D2FO00546H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2FO00546H</ArticleId><ArticleId IdType="pubmed">35703137</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav A., Jagtap S., Vyavahare S., Sharbidre A., Kunchiraman B. Reviewing the potential of probiotics, prebiotics and synbiotics: Advancements in treatment of ulcerative colitis. Front. Cell. Infect. Microbiol. 2023;13:1268041. doi: 10.3389/fcimb.2023.1268041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1268041</ArticleId><ArticleId IdType="pmc">PMC10739422</ArticleId><ArticleId IdType="pubmed">38145046</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatova I., Arsov A., Petrova P., Petrov K. Prebiotic Effects of &#x3b1;- and &#x3b2;-Galactooligosaccharides: The Structure-Function Relation. Molecules. 2025;30:803. doi: 10.3390/molecules30040803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules30040803</ArticleId><ArticleId IdType="pmc">PMC11858185</ArticleId><ArticleId IdType="pubmed">40005114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei Z., Yuan J., Li D. Biological activity of galacto-oligosaccharides: A review. Front. Microbiol. 2022;13:993052. doi: 10.3389/fmicb.2022.993052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.993052</ArticleId><ArticleId IdType="pmc">PMC9485631</ArticleId><ArticleId IdType="pubmed">36147858</ArticleId></ArticleIdList></Reference><Reference><Citation>Roselli M., Maruszak A., Grimaldi R., Harthoorn L., Finamore A. Galactooligosaccharide Treatment Alleviates DSS-Induced Colonic Inflammation in Caco-2 Cell Model. Front. Nutr. 2022;9:862974. doi: 10.3389/fnut.2022.862974.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.862974</ArticleId><ArticleId IdType="pmc">PMC9047546</ArticleId><ArticleId IdType="pubmed">35495925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H., Tao X., Sun Z., Hao W., Wei X. Galactooligosaccharides protects against DSS-induced murine colitis through regulating intestinal flora and inhibiting NF-&#x3ba;B pathway. Life Sci. 2020;242:117220. doi: 10.1016/j.lfs.2019.117220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.117220</ArticleId><ArticleId IdType="pubmed">31881230</ArticleId></ArticleIdList></Reference><Reference><Citation>God&#xed;nez-M&#xe9;ndez L.A., Gurrola-D&#xed;az C.M., Zepeda-Nu&#xf1;o J.S., Vega-Maga&#xf1;a N., Lopez-Roa R.I., &#xcd;&#xf1;iguez-Guti&#xe9;rrez L., Garc&#xed;a-L&#xf3;pez P.M., Fafutis-Morris M., Delgado-Rizo V. In Vivo Healthy Benefits of Galacto-Oligosaccharides from Lupinus albus (LA-GOS) in Butyrate Production through Intestinal Microbiota. Biomolecules. 2021;11:1658. doi: 10.3390/biom11111658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11111658</ArticleId><ArticleId IdType="pmc">PMC8615603</ArticleId><ArticleId IdType="pubmed">34827656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mota J., Casimiro S., Fernandes J., Hartmann R.M., Schemitt E., Picada J., Costa L., Marroni N., Raymundo A., Lima A., et al. Lupin Protein Concentrate as a Novel Functional Food Additive That Can Reduce Colitis-Induced Inflammation and Oxidative Stress. Nutrients. 2022;14:2102. doi: 10.3390/nu14102102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102102</ArticleId><ArticleId IdType="pmc">PMC9143369</ArticleId><ArticleId IdType="pubmed">35631241</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira A., Ramos F., Sanches Silva A. Lupin (Lupinus albus L.) Seeds: Balancing the Good and the Bad and Addressing Future Challenges. Molecules. 2022;27:8557. doi: 10.3390/molecules27238557.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27238557</ArticleId><ArticleId IdType="pmc">PMC9737668</ArticleId><ArticleId IdType="pubmed">36500649</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson B., Eyice &#xd6;., Koumoutsos I., Lomer M.C., Irving P.M., Lindsay J.O., Whelan K. Prebiotic Galactooligosaccharide Supplementation in Adults with Ulcerative Colitis: Exploring the Impact on Peripheral Blood Gene Expression, Gut Microbiota, and Clinical Symptoms. Nutrients. 2021;13:3598. doi: 10.3390/nu13103598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13103598</ArticleId><ArticleId IdType="pmc">PMC8537576</ArticleId><ArticleId IdType="pubmed">34684597</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M.E.V., Gustafsson J.K., Holm&#xe9;n-Larsson J., Jabbar K.S., Xia L., Xu H., Ghishan F.K., Carvalho F.A., Gewirtz A.T., Sj&#xf6;vall H., et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63:281&#x2013;291. doi: 10.1136/gutjnl-2012-303207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2012-303207</ArticleId><ArticleId IdType="pmc">PMC3740207</ArticleId><ArticleId IdType="pubmed">23426893</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X., Zhang Y., Li W., Yin J., Zhang B., Wang J., Wang S. Differential responses on gut microbiota and microbial metabolome of 2&#x2032;-fucosyllactose and galactooligosaccharide against DSS-induced colitis. Food Res. Int. 2022;162:112072. doi: 10.1016/j.foodres.2022.112072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodres.2022.112072</ArticleId><ArticleId IdType="pubmed">36461391</ArticleId></ArticleIdList></Reference><Reference><Citation>Do K.-H., Ko S.-H., Kim K.B., Seo K., Lee W.-K. Comparative Study of Intestinal Microbiome in Patients with Ulcerative Colitis and Healthy Controls in Korea. Microorganisms. 2023;11:2750. doi: 10.3390/microorganisms11112750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11112750</ArticleId><ArticleId IdType="pmc">PMC10673479</ArticleId><ArticleId IdType="pubmed">38004761</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinero N., Taladrid D., Zorraqu&#xed;n-Pe&#xf1;a I., De Celis M., Belda I., Mira A., Bartolom&#xe9; B., Moreno-Arribas M.V. Ulcerative Colitis Seems to Imply Oral Microbiome Dysbiosis. Curr. Issues Mol. Biol. 2022;44:1513&#x2013;1527. doi: 10.3390/cimb44040103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb44040103</ArticleId><ArticleId IdType="pmc">PMC9164047</ArticleId><ArticleId IdType="pubmed">35723361</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima A., Nomura R., Ooshima T., Nakano K. Aggravation of Inflammatory Bowel Diseases by oral streptococci. Oral Dis. 2013;20:359&#x2013;366. doi: 10.1111/odi.12125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12125</ArticleId><ArticleId IdType="pubmed">23679203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima A., Nakano K., Wada K., Takahashi H., Katayama K., Yoneda M., Higurashi T., Nomura R., Hokamura K., Muranaka Y., et al. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci. Rep. 2012;2:332. doi: 10.1038/srep00332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00332</ArticleId><ArticleId IdType="pmc">PMC3312205</ArticleId><ArticleId IdType="pubmed">22451861</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca M., Celano G., Calabrese F.M., Portincasa P., Gobbetti M., De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms. 2020;8:573. doi: 10.3390/microorganisms8040573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8040573</ArticleId><ArticleId IdType="pmc">PMC7232163</ArticleId><ArticleId IdType="pubmed">32326636</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto H., Sasahira M., Go T.T., Yo S., Ninomiya T., Osawa M., Handa O., Umegami E., Inoue R., Shiotani A. Characteristics of Mucosa-Associated Microbiota in Ulcerative Colitis Patients with 5-Aminosalicylic Acid Intolerance. Biomedicines. 2024;12:2125. doi: 10.3390/biomedicines12092125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12092125</ArticleId><ArticleId IdType="pmc">PMC11428711</ArticleId><ArticleId IdType="pubmed">39335641</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Lkhagva E., Kim S., Zhai C., Islam M.M., Kim H.J., Hong S.-T. The gut microbe pair of Oribacterium sp. GMB0313 and Ruminococcus sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity. Gut Microbes. 2024;16:2342497. doi: 10.1080/19490976.2024.2342497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2024.2342497</ArticleId><ArticleId IdType="pmc">PMC11028030</ArticleId><ArticleId IdType="pubmed">38635321</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H., Yeo S., Kang S., Huh C.S. Longitudinal Microbiome Analysis in a Dextran Sulfate Sodium-Induced Colitis Mouse Model. Microorganisms. 2021;9:370. doi: 10.3390/microorganisms9020370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9020370</ArticleId><ArticleId IdType="pmc">PMC7917662</ArticleId><ArticleId IdType="pubmed">33673349</ArticleId></ArticleIdList></Reference><Reference><Citation>Britto S.L., Krishna M., Kellermayer R. Weight loss is a sufficient and economical single outcome measure of murine dextran sulfate sodium colitis. FASEB Bioadv. 2019;1:493&#x2013;497. doi: 10.1096/fba.2019-00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fba.2019-00035</ArticleId><ArticleId IdType="pmc">PMC6996316</ArticleId><ArticleId IdType="pubmed">32123846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassaing B., Aitken J.D., Malleshappa M., Vijay-Kumar M. Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Curr. Protoc. Immunol. 2014;104 doi: 10.1002/0471142735.im1525s104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142735.im1525s104</ArticleId><ArticleId IdType="pmc">PMC3980572</ArticleId><ArticleId IdType="pubmed">24510619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Jiang X., Chen X., Wang Z., Xia J., Wang B., Wang M., Ding Y. Identification of differentially expressed genes associated with ferroptosis in ulcerative colitis. PLoS ONE. 2025;20:e0327990. doi: 10.1371/journal.pone.0327990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0327990</ArticleId><ArticleId IdType="pmc">PMC12306769</ArticleId><ArticleId IdType="pubmed">40729322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajer L., Kverka M., Kostovcik M., Macinga P., Dvorak J., Stehlikova Z., Brezina J., Wohl P., Spicak J., Drastich P. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis. World J. Gastroenterol. 2017;23:4548. doi: 10.3748/wjg.v23.i25.4548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i25.4548</ArticleId><ArticleId IdType="pmc">PMC5504370</ArticleId><ArticleId IdType="pubmed">28740343</ArticleId></ArticleIdList></Reference><Reference><Citation>Olshan K.L., Zomorrodi A.R., Pujolassos M., Troisi J., Khan N., Fanelli B., Kenyon V., Fasano A., Leonard M.M. Microbiota and Metabolomic Patterns in the Breast Milk of Subjects with Celiac Disease on a Gluten-Free Diet. Nutrients. 2021;13:2243. doi: 10.3390/nu13072243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13072243</ArticleId><ArticleId IdType="pmc">PMC8308312</ArticleId><ArticleId IdType="pubmed">34210038</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatahi-Bafghi M. Characterization of the Rothia spp. and their role in human clinical infections. Infect. Genet. Evol. 2021;93:104877. doi: 10.1016/j.meegid.2021.104877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104877</ArticleId><ArticleId IdType="pubmed">33905886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihara Y., Ogino H., Tanaka M., Ihara E., Fukaura K., Nishioka K., Chinen T., Tanaka Y., Nakayama J., Kang D., et al. Mucosa-associated gut microbiota reflects clinical course of ulcerative colitis. Sci. Rep. 2021;11:13743. doi: 10.1038/s41598-021-92870-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92870-0</ArticleId><ArticleId IdType="pmc">PMC8253849</ArticleId><ArticleId IdType="pubmed">34215773</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;v&#xe9;r Z., Johansen Nordskag V., B&#xe1;n &#xc1;., Gajd&#xe1;cs M., Urb&#xe1;n E. The role of Actinomyces spp. and related organisms in cervicofacial infections: Pathomechanism, diagnosis and therapeutic aspects. Anaerobe. 2023;82:102767. doi: 10.1016/j.anaerobe.2023.102767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2023.102767</ArticleId><ArticleId IdType="pubmed">37482285</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Li Y., Zhou Y., Wang C., Wu B., Wan J. Actinomyces and Alimentary Tract Diseases: A Review of Its Biological Functions and Pathology. BioMed Res. Int. 2018;2018:3820215. doi: 10.1155/2018/3820215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/3820215</ArticleId><ArticleId IdType="pmc">PMC6129341</ArticleId><ArticleId IdType="pubmed">30225251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dioguardi M., Crincoli V., Laino L., Alovisi M., Sovereto D., Lo Muzio L., Troiano G. Prevalence of Bacteria of Genus Actinomyces in Persistent Extraradicular Lesions&#x2014;Systematic Review. J. Clin. Med. 2020;9:457. doi: 10.3390/jcm9020457.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020457</ArticleId><ArticleId IdType="pmc">PMC7074192</ArticleId><ArticleId IdType="pubmed">32046071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Lv Z., Chen F., Zhang Y., Xu Z., Huo J., Liu W., Yu S., Tuersun A., Zhao J., et al. Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in young-onset colorectal cancer. Front. Immunol. 2022;13:1008975. doi: 10.3389/fimmu.2022.1008975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1008975</ArticleId><ArticleId IdType="pmc">PMC9481283</ArticleId><ArticleId IdType="pubmed">36119074</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins K.H., Schwartz D.J., Lenz K.L., Harris C.A., Guilak F. Taxonomic changes in the gut microbiota are associated with cartilage damage independent of adiposity, high fat diet, and joint injury. Sci. Rep. 2021;11:14560. doi: 10.1038/s41598-021-94125-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94125-4</ArticleId><ArticleId IdType="pmc">PMC8282619</ArticleId><ArticleId IdType="pubmed">34267289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., Chen X., Ren H., Sun R., Liu W., et al. Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut. 2021;70:1253&#x2013;1265. doi: 10.1136/gutjnl-2020-323826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn J., Li L., Zhang L., Settem R.P., Honma K., Sharma A., Falkner K.L., Novak J.M., Sun Y., Kirkwood K.L. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4+ T cells. Mol. Oral Microbiol. 2022;37:42&#x2013;52. doi: 10.1111/omi.12359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12359</ArticleId><ArticleId IdType="pmc">PMC9353576</ArticleId><ArticleId IdType="pubmed">34958712</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleming B.A., Mulvey M.A. Commensal Strains of Neisseria Use DNA to Poison Their Pathogenic Rivals. Cell Host Microbe. 2019;26:156&#x2013;158. doi: 10.1016/j.chom.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.07.014</ArticleId><ArticleId IdType="pubmed">31415746</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho E.L., Ogle J.M., Finck A.M. The Human Microbiome as a Focus of Antibiotic Discovery: Neisseria mucosa Displays Activity Against Neisseria gonorrhoeae. Front. Microbiol. 2020;11:577762. doi: 10.3389/fmicb.2020.577762.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.577762</ArticleId><ArticleId IdType="pmc">PMC7744932</ArticleId><ArticleId IdType="pubmed">33343520</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim W.J., Higashi D., Goytia M., Rend&#xf3;n M.A., Pilligua-Lucas M., Bronnimann M., McLean J.A., Duncan J., Trees D., Jerse A.E., et al. Commensal Neisseria Kill Neisseria gonorrhoeae through a DNA-Dependent Mechanism. Cell Host Microbe. 2019;26:228&#x2013;239.e8. doi: 10.1016/j.chom.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.07.003</ArticleId><ArticleId IdType="pmc">PMC6728082</ArticleId><ArticleId IdType="pubmed">31378677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Jha R., Li A., Liu H., Zhang Z., Zhang C., Zhai Q., Zhang J. Probiotics (Lactobacillus plantarum HNU082) Supplementation Relieves Ulcerative Colitis by Affecting Intestinal Barrier Functions, Immunity-Related Gene Expression, Gut Microbiota, and Metabolic Pathways in Mice. Microbiol. Spectr. 2022;10:e01651-22. doi: 10.1128/spectrum.01651-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01651-22</ArticleId><ArticleId IdType="pmc">PMC9769980</ArticleId><ArticleId IdType="pubmed">36321893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Zhang X., Liu X., Zhao Z., Tao S., Xu Q., Zhao J., Dai Z., Zhang G., Han D., et al. Galactooligosaccharides and Limosilactobacillus reuteri synergistically alleviate gut inflammation and barrier dysfunction by enriching Bacteroides acidifaciens for pentadecanoic acid biosynthesis. Nat. Commun. 2024;15:9291. doi: 10.1038/s41467-024-53144-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-53144-1</ArticleId><ArticleId IdType="pmc">PMC11519483</ArticleId><ArticleId IdType="pubmed">39468026</ArticleId></ArticleIdList></Reference><Reference><Citation>Overstreet A.-M.C., Ramer-Tait A.E., Suchodolski J.S., Hostetter J.M., Wang C., Jergens A.E., Phillips G.J., Wannemuehler M.J. Temporal Dynamics of Chronic Inflammation on the Cecal Microbiota in IL-10-/- Mice. Front. Immunol. 2021;11:585431. doi: 10.3389/fimmu.2020.585431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.585431</ArticleId><ArticleId IdType="pmc">PMC7921487</ArticleId><ArticleId IdType="pubmed">33664728</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Wei J., Jia X., Luan F., Man M., Ma X., Luo Y., Li Y., Li N., Wang Q., et al. Changes in the microbiota in different intestinal segments of mice with sepsis. Front. Cell. Infect. Microbiol. 2023;12:954347. doi: 10.3389/fcimb.2022.954347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.954347</ArticleId><ArticleId IdType="pmc">PMC9871835</ArticleId><ArticleId IdType="pubmed">36704101</ArticleId></ArticleIdList></Reference><Reference><Citation>Marteau P., Pochart P., Dor&#xe9; J., B&#xe9;ra-Maillet C., Bernalier A., Corthier G. Comparative Study of Bacterial Groups within the Human Cecal and Fecal Microbiota. Appl. Environ. Microbiol. 2001;67:4939&#x2013;4942. doi: 10.1128/AEM.67.10.4939-4942.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.67.10.4939-4942.2001</ArticleId><ArticleId IdType="pmc">PMC93255</ArticleId><ArticleId IdType="pubmed">11571208</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K., Tan J., Lin D., Jiang H., Chu Y., Zhou L., Zhang J., Lu Y. Gut microbes of the cecum versus the colon drive more severe lethality and multi-organ damage. Int. Immunopharmacol. 2025;147:114029. doi: 10.1016/j.intimp.2025.114029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2025.114029</ArticleId><ArticleId IdType="pubmed">39793233</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavelle A., Lennon G., O&#x2019;Sullivan O., Docherty N., Balfe A., Maguire A., Mulcahy H.E., Doherty G., O&#x2019;Donoghue D., Hyland J., et al. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut. 2015;64:1553&#x2013;1561. doi: 10.1136/gutjnl-2014-307873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2014-307873</ArticleId><ArticleId IdType="pmc">PMC4602252</ArticleId><ArticleId IdType="pubmed">25596182</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.J., Smith C.P., Wilbur R.R., Cain C.P., Kallu S.R., Valasapalli S., Sahoo A., Guda M.R., Tsung A.J., Velpula K.K. An overview of MCT1 and MCT4 in GBM: Small molecule transporters with large implications. Am. J. Cancer Res. 2018;8:1967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220151</ArticleId><ArticleId IdType="pubmed">30416849</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisel P., Schaeffeler E., Schwab M. Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug Therapy. Clin. Transl. Sci. 2018;11:352&#x2013;364. doi: 10.1111/cts.12551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cts.12551</ArticleId><ArticleId IdType="pmc">PMC6039204</ArticleId><ArticleId IdType="pubmed">29660777</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanaga T., Takebe K., Kato I., Karaki S.-I., Kuwahara A. Cellular expression of monocarboxylate transporters (MCT) in the digestive tract of the mouse, rat, and humans, with special reference to slc5a8. Biomed. Res. 2006;27:243&#x2013;254. doi: 10.2220/biomedres.27.243.</Citation><ArticleIdList><ArticleId IdType="doi">10.2220/biomedres.27.243</ArticleId><ArticleId IdType="pubmed">17099289</ArticleId></ArticleIdList></Reference><Reference><Citation>Deleu S., Arnauts K., Deprez L., Machiels K., Ferrante M., Huys G.R.B., Thevelein J.M., Raes J., Vermeire S. High Acetate Concentration Protects Intestinal Barrier and Exerts Anti-Inflammatory Effects in Organoid-Derived Epithelial Monolayer Cultures from Patients with Ulcerative Colitis. Int. J. Mol. Sci. 2023;24:768. doi: 10.3390/ijms24010768.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010768</ArticleId><ArticleId IdType="pmc">PMC9821118</ArticleId><ArticleId IdType="pubmed">36614212</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose S., Ramesh V., Locasale J.W. Acetate Metabolism in Physiology, Cancer, and Beyond. Trends Cell Biol. 2019;29:695&#x2013;703. doi: 10.1016/j.tcb.2019.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2019.05.005</ArticleId><ArticleId IdType="pmc">PMC6699882</ArticleId><ArticleId IdType="pubmed">31160120</ArticleId></ArticleIdList></Reference><Reference><Citation>Babl N., Decking S.-M., Voll F., Althammer M., Sala-Hojman A., Ferretti R., Korf C., Schmidl C., Schmidleithner L., Nerb B., et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J. Immunother. Cancer. 2023;11:e007349. doi: 10.1136/jitc-2023-007349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2023-007349</ArticleId><ArticleId IdType="pmc">PMC10603342</ArticleId><ArticleId IdType="pubmed">37880183</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.K., Lee I., Bang H., Kim H.C., Lee W.Y., Yun S.H., Lee J., Lee S.J., Park Y.S., Kim K.-M., et al. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis. Mol. Cancer Ther. 2018;17:838&#x2013;848. doi: 10.1158/1535-7163.MCT-17-0535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-17-0535</ArticleId><ArticleId IdType="pubmed">29483215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X., Liu C., Ding Y., Ni Y., Ji F., Lau H.C.H., Jiang L., Sung J.J., Wong S.H., Yu J. Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells. Gut. 2023;72:2112&#x2013;2122. doi: 10.1136/gutjnl-2023-330291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2023-330291</ArticleId><ArticleId IdType="pmc">PMC10579466</ArticleId><ArticleId IdType="pubmed">37491158</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nzel D., Yu A.S.L. Claudins and the Modulation of Tight Junction Permeability. Physiol. Rev. 2013;93:525&#x2013;569. doi: 10.1152/physrev.00019.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00019.2012</ArticleId><ArticleId IdType="pmc">PMC3768107</ArticleId><ArticleId IdType="pubmed">23589827</ArticleId></ArticleIdList></Reference><Reference><Citation>Mees S.T., Mennigen R., Spieker T., Rijcken E., Senninger N., Haier J., Bruewer M. Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: Upregulation of claudin-1, claudin-3, claudin-4, and &#x3b2;-catenin. Int. J. Colorectal Dis. 2009;24:361&#x2013;368. doi: 10.1007/s00384-009-0653-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00384-009-0653-y</ArticleId><ArticleId IdType="pubmed">19184060</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sadi R., Khatib K., Guo S., Ye D., Youssef M., Ma T. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am. J. Physiol.-Gastrointest. Liver Physiol. 2011;300:G1054&#x2013;G1064. doi: 10.1152/ajpgi.00055.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00055.2011</ArticleId><ArticleId IdType="pmc">PMC3119114</ArticleId><ArticleId IdType="pubmed">21415414</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetrano S., Rescigno M., Rosaria Cera M., Correale C., Rumio C., Doni A., Fantini M., Sturm A., Borroni E., Repici A., et al. Unique Role of Junctional Adhesion Molecule-A in Maintaining Mucosal Homeostasis in Inflammatory Bowel Disease. Gastroenterology. 2008;135:173&#x2013;184. doi: 10.1053/j.gastro.2008.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2008.04.002</ArticleId><ArticleId IdType="pubmed">18514073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo W.-T., Zuo L., Odenwald M.A., Madha S., Singh G., Gurniak C.B., Abraham C., Turner J.R. The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair. Gastroenterology. 2021;161:1924&#x2013;1939. doi: 10.1053/j.gastro.2021.08.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.08.047</ArticleId><ArticleId IdType="pmc">PMC8605999</ArticleId><ArticleId IdType="pubmed">34478742</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M.-D. Mechanism of Diapedesis: Importance of the Transcellular Route. Adv. Immunol. 2016;129:25&#x2013;53. doi: 10.1016/bs.ai.2015.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ai.2015.09.001</ArticleId><ArticleId IdType="pmc">PMC4889131</ArticleId><ArticleId IdType="pubmed">26791857</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan S., Weight C.M., Luissint A.-C., Hilgarth R.S., Brazil J.C., Ettel M., Nusrat A., Parkos C.A. Role of JAM-A tyrosine phosphorylation in epithelial barrier dysfunction during intestinal inflammation. Mol. Biol. Cell. 2019;30:566&#x2013;578. doi: 10.1091/mbc.E18-08-0531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E18-08-0531</ArticleId><ArticleId IdType="pmc">PMC6589701</ArticleId><ArticleId IdType="pubmed">30625033</ArticleId></ArticleIdList></Reference><Reference><Citation>Luissint A.-C., Parkos C.A., Nusrat A. Inflammation and the Intestinal Barrier: Leukocyte&#x2013;Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. Gastroenterology. 2016;151:616&#x2013;632. doi: 10.1053/j.gastro.2016.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.07.008</ArticleId><ArticleId IdType="pmc">PMC5317033</ArticleId><ArticleId IdType="pubmed">27436072</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim S., Zhu X., Luo X., Feng Y., Wang J. PIK3R3 regulates ZO-1 expression through the NF-&#x3ba;B pathway in inflammatory bowel disease. Int. Immunopharmacol. 2020;85:106610. doi: 10.1016/j.intimp.2020.106610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106610</ArticleId><ArticleId IdType="pubmed">32473571</ArticleId></ArticleIdList></Reference><Reference><Citation>Poritz L.S., Garver K.I., Green C., Fitzpatrick L., Ruggiero F., Koltun W.A. Loss of the Tight Junction Protein ZO-1 in Dextran Sulfate Sodium Induced Colitis. J. Surg. Res. 2007;140:12&#x2013;19. doi: 10.1016/j.jss.2006.07.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2006.07.050</ArticleId><ArticleId IdType="pubmed">17418867</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Guan Y., Sun Y., Zheng C. Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis Patients. Am. J. Med. Sci. 2019;357:195&#x2013;204. doi: 10.1016/j.amjms.2018.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2018.11.011</ArticleId><ArticleId IdType="pubmed">30638599</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-C., Tsai K.-W., Liao J.-B., Kuo W.-T., Chang Y.-C., Yang Y.-F. High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging. Sci. Rep. 2022;12:1496. doi: 10.1038/s41598-022-05631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05631-y</ArticleId><ArticleId IdType="pmc">PMC8795112</ArticleId><ArticleId IdType="pubmed">35087173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulewicz P., Ciesio&#x142;ka D., Frias J., Vidal-Valverde C., Frejnagel S., Trojanowska K., Gulewicz K. Simple Method of Isolation and Purification of &#x3b1;-Galactosides from Legumes. J. Agric. Food Chem. 2000;48:3120&#x2013;3123. doi: 10.1021/jf000210v.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf000210v</ArticleId><ArticleId IdType="pubmed">10956079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon J., Lee C., Heo S., Kim B., Hyun C.-K. DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice. Sci. Rep. 2021;11:5283. doi: 10.1038/s41598-021-84761-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84761-1</ArticleId><ArticleId IdType="pmc">PMC7935975</ArticleId><ArticleId IdType="pubmed">33674694</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanaka H., Tsukui M., Takada S., Kurashina K., Choi Y.L., Soda M., Yamashita Y., Haruta H., Hamada T., Ueno T., et al. Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. Cancer Sci. 2010;101:54&#x2013;59. doi: 10.1111/j.1349-7006.2009.01348.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1349-7006.2009.01348.x</ArticleId><ArticleId IdType="pmc">PMC11159747</ArticleId><ArticleId IdType="pubmed">19780758</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang I., An B.S., Yang H., Kang H.S., Jung E.M., Jeung E.B. Tissue-specific expression of occludin, zona occludens-1, and junction adhesion molecule a in the duodenum, ileum, colon, kidney, liver, lung, brain, and skeletal muscle of C57BL mice. J. Physiol. Pharmacol. 2013;64:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">23568966</ArticleId></ArticleIdList></Reference><Reference><Citation>Schutkowski A., Wege N., Stangl G.I., K&#xf6;nig B. Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice. PLoS ONE. 2014;9:e112118. doi: 10.1371/journal.pone.0112118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112118</ArticleId><ArticleId IdType="pmc">PMC4229183</ArticleId><ArticleId IdType="pubmed">25390336</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa C., Ishizuka N., Hayashi H., Fujii N., Manabe A., Tabuchi Y., Matsunaga T., Endo S., Ikari A. Up-regulation of claudin-2 expression by aldosterone in colonic epithelial cells of mice fed with NaCl-depleted diets. Sci. Rep. 2017;7:12223. doi: 10.1038/s41598-017-12494-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-12494-1</ArticleId><ArticleId IdType="pmc">PMC5610316</ArticleId><ArticleId IdType="pubmed">28939904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad R., Chaturvedi R., Olivares-Villag&#xf3;mez D., Habib T., Asim M., Shivesh P., Polk D.B., Wilson K.T., Washington M.K., Van Kaer L., et al. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Mucosal Immunol. 2014;7:1340&#x2013;1353. doi: 10.1038/mi.2014.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2014.21</ArticleId><ArticleId IdType="pmc">PMC4221190</ArticleId><ArticleId IdType="pubmed">24670427</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E., Stark M.A., Zarbock A., Burcin T.L., Vaswani D., Foley P., Ley K. Interleukin-17A inhibits the expansion of IL-17A-producing T cells in mice through &#x201c;short-loop&#x201d; inhibition via IL-17 receptor. J. Immunol. 2009;181:1357&#x2013;1364. doi: 10.4049/jimmunol.181.2.1357.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.2.1357</ArticleId><ArticleId IdType="pmc">PMC2586908</ArticleId><ArticleId IdType="pubmed">18606690</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y.-B., Zhao D.-Y., Qi Q.-Q., Long X., Li X., Chen F.-X., Zuo X.-L. BDNF modulates intestinal barrier integrity through regulating the expression of tight junction proteins. Neurogastroenterol. Motil. 2017;29:e12967. doi: 10.1111/nmo.12967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12967</ArticleId><ArticleId IdType="pubmed">27747999</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C.-H., Kim N., Sohn S.H., Lee S.M., Nam R.H., Na H.Y., Lee D.H., Surh Y.-J. Effects of 17beta;-Estradiol on Colonic Permeability and Inflammation in an Azoxymethane/Dextran Sulfate Sodium-Induced Colitis Mouse Model. Gut Liver. 2018;12:682&#x2013;693. doi: 10.5009/gnl18221.</Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl18221</ArticleId><ArticleId IdType="pmc">PMC6254630</ArticleId><ArticleId IdType="pubmed">30400733</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40791066</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1940-2465</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of surgical pathology</Title><ISOAbbreviation>Int J Surg Pathol</ISOAbbreviation></Journal><ArticleTitle>Tactile Corpuscle-Like Bodies in Urinary Bladder Mucosa.</ArticleTitle><Pagination><StartPage>10668969251361179</StartPage><MedlinePgn>10668969251361179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10668969251361179</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Milesi</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pathology Unit, C.D.I. Centro Diagnostico Italiano S.p.A. Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verani</LastName><ForeName>Renzo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Urology Unit, Casa di cura Figlie di Camillo, Cremona, Italy.</Affiliation><Identifier Source="RINGGOLD">47178</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellegara</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8604-0094</Identifier><AffiliationInfo><Affiliation>Pathology Unit, C.D.I. Centro Diagnostico Italiano S.p.A. Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Surg Pathol</MedlineTA><NlmUniqueID>9314927</NlmUniqueID><ISSNLinking>1066-8969</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Wagner-Meissner corpuscles</Keyword><Keyword MajorTopicYN="N">tactile corpuscle-like bodies</Keyword><Keyword MajorTopicYN="N">urinary bladder mucosa</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40791066</ArticleId><ArticleId IdType="doi">10.1177/10668969251361179</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40564263</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2615</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>12</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>10</Day></PubDate></JournalIssue><Title>Animals : an open access journal from MDPI</Title><ISOAbbreviation>Animals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Preliminary Study of <i>CCR9</i> and <i>MAdCAM-1</i> Upregulation and Immune Imbalance in Canine Chronic Enteropathy: Findings Based on Histopathological Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1710</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ani15121710</ELocationID><Abstract><AbstractText>Canine chronic enteropathy (CE) is a gastrointestinal disorder characterized by persistent or recurrent digestive symptoms lasting more than three weeks. It shares similarities with human inflammatory bowel disease but its immunopathogenesis remains poorly characterized in dogs. The aim of this study was to characterize the local and systemic immune profile of dogs with CE by assessing cytokine and chemokine expression in serum and intestinal tissue, as well as the mRNA expression of immune-related receptors such as integrins, chemokine receptors, and cytokines. Duodenal biopsies and blood samples were collected from five dogs diagnosed with a CE and five healthy controls. Serum concentrations of cytokines and chemokines were determined by multiplex ELISA, and mRNA expression in the intestinal mucosa was analyzed by quantitative PCR. Dogs with a CE showed increased expression of pro-inflammatory cytokines, including <i>TNF-&#x3b1;</i> and <i>IFN-&#x3b3;</i>, and increased concentrations of chemokines such as CXCL10 and CCL2 in both serum and tissue samples. Increased mRNA expression of the chemokine receptor <i>CCR9</i> and the adhesion molecule <i>MAdCAM-1</i> were also observed in intestinal samples. These findings provide new insights into the immune response involved in CE and may aid the development of future diagnostic biomarkers and targeted therapies for canine chronic enteropathies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pino</LastName><ForeName>Macarena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5413-8588</Identifier><AffiliationInfo><Affiliation>Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 8200010, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Veterinary Research Laboratory (LaCIV), Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago 8330015, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Galia</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8415-7918</Identifier><AffiliationInfo><Affiliation>Central Veterinary Research Laboratory (LaCIV), Facultad de Ciencias Veterinarias y Pecuarias, Universidad de Chile, Santiago 8330015, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltr&#xe1;n</LastName><ForeName>Caroll</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Immunogastroenterology, Biochemistry and Immunology Department, Faculty of Pharmacy, Universidad de Concepci&#xf3;n, Concepci&#xf3;n 4070386, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine Faculty, Universidad de Chile, Santiago 8330015, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3551-3722</Identifier><AffiliationInfo><Affiliation>Centro de Biomedicina, Universidad Mayor, Santiago 7500994, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Ismael</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9672-8423</Identifier><AffiliationInfo><Affiliation>Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 8200010, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villegas</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9556-4655</Identifier><AffiliationInfo><Affiliation>Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andr&#xe9;s Bello, Santiago 8370035, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cifuentes</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0266-8189</Identifier><AffiliationInfo><Affiliation>Escuela de Medicina Veterinaria, Facultad de Agronom&#xed;a e Ingenier&#xed;a Forestal, Facultad de Ciencias Biol&#xf3;gicas y Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago 8331150, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ESPA Diagn&#xf3;stico Ltd.a., Santiago 7500961, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siel</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7735-1218</Identifier><AffiliationInfo><Affiliation>Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 8200010, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Biomedicina, Universidad Mayor, Santiago 7500994, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>3190649</GrantID><Agency>FONDECYT</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Animals (Basel)</MedlineTA><NlmUniqueID>101635614</NlmUniqueID><ISSNLinking>2076-2615</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CCR9</Keyword><Keyword MajorTopicYN="N">MAdCAM-1</Keyword><Keyword MajorTopicYN="N">canine</Keyword><Keyword MajorTopicYN="N">chemokines</Keyword><Keyword MajorTopicYN="N">chronic inflammatory enteritis</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">immune profile</Keyword></KeywordList><CoiStatement>Co-author Federico Cifuentes is affiliated with ESPA Diagnostics in his role as a researcher; however, this affiliation did not influence the conduct or outcomes of the study. The authors declare that there are no other conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40564263</ArticleId><ArticleId IdType="pmc">PMC12189423</ArticleId><ArticleId IdType="doi">10.3390/ani15121710</ArticleId><ArticleId IdType="pii">ani15121710</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dandrieux J., Mansfield C.S. Chronic Enteropathy in Canines: Prevalence, Impact and Management Strategies. Vet. Med. Res. Rep. 2019;10:203&#x2013;214. doi: 10.2147/VMRR.S162774.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VMRR.S162774</ArticleId><ArticleId IdType="pmc">PMC6902862</ArticleId><ArticleId IdType="pubmed">31828025</ArticleId></ArticleIdList></Reference><Reference><Citation>Junginger J., Lemensieck F., Moore P.F., Schwittlick U., Nolte I., Hewicker-Trautwein M. Canine gut dendritic cells in the steady state and in inflammatory bowel disease. Innate Immun. 2014;20:145&#x2013;160. doi: 10.1177/1753425913485475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1753425913485475</ArticleId><ArticleId IdType="pubmed">23723379</ArticleId></ArticleIdList></Reference><Reference><Citation>Procoli F. Inflammatory Bowel Disease, Food-Responsive, Antibiotic-Responsive Diarrhoea, Protein Losing Enteropathy. Adv. Small Anim. Care. 2020;1:127&#x2013;414. doi: 10.1016/j.yasa.2020.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yasa.2020.07.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandrieux J.R.S. Inflammatory Bowel Disease versus Chronic Enteropathy in Dogs: Are They One and the Same? J. Small Anim. Pract. 2016;57:589&#x2013;599. doi: 10.1111/jsap.12588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsap.12588</ArticleId><ArticleId IdType="pubmed">27747868</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerquetella M., Rossi G., Suchodolski J.S., Schmitz S.S., Allenspach K., Rodr&#xed;guez-Franco F., Furlanello T., Gavazza A., Marchegiani A., Unterer S., et al. Proposal for Rational Antibacterial Use in the Diagnosis and Treatment of Dogs with Chronic Diarrhoea. J. Small Anim. Pract. 2020;61:211&#x2013;215. doi: 10.1111/jsap.13122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsap.13122</ArticleId><ArticleId IdType="pmc">PMC7079140</ArticleId><ArticleId IdType="pubmed">32065388</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupouy-Manescau N., M&#xe9;ric T., S&#xe9;n&#xe9;cat O., Drut A., Valentin S., Leal R.O., Hernandez J. Updating the Classification of Chronic Inflammatory Enteropathies in Dogs. Animals. 2024;14:681. doi: 10.3390/ani14050681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani14050681</ArticleId><ArticleId IdType="pmc">PMC10931249</ArticleId><ArticleId IdType="pubmed">38473066</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilla R., Suchodolski J.S. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease. Front. Vet. Sci. 2020;6:498. doi: 10.3389/fvets.2019.00498.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2019.00498</ArticleId><ArticleId IdType="pmc">PMC6971114</ArticleId><ArticleId IdType="pubmed">31993446</ArticleId></ArticleIdList></Reference><Reference><Citation>Garz&#xed;a-Sancho M., Rodr&#xed;guez-Franco F., Sainz A., Mancho C., Rodr&#xed;guez A. Evaluation of Clinical, Macroscopic, and Histopathologic Response to Treatment in Nonhypoproteinemic Dogs with Lymphocytic-Plasmacytic Enteritis. J. Vet. Intern. Med. 2007;21:11&#x2013;17. doi: 10.1111/j.1939-1676.2007.tb02922.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2007.tb02922.x</ArticleId><ArticleId IdType="pubmed">17338144</ArticleId></ArticleIdList></Reference><Reference><Citation>German A.J., Helps C.R., Hall E.J., Day M.J. Cytokine mRNA Expression in Mucosal Biopsies from German Shepherd Dogs with Small Intestinal Enteropathies. Dig. Dis. Sci. 2000;45:7&#x2013;17. doi: 10.1023/A:1005436721798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1005436721798</ArticleId><ArticleId IdType="pubmed">10695606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jergens A.E. Inflammatory bowel disease in veterinary medicine. Front. Biosci. 2012;4:1404&#x2013;1419. doi: 10.2741/e470.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e470</ArticleId><ArticleId IdType="pubmed">22201965</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogeshpriya S., Veeraselvam M., Krishnakumar S., Arulkumar T., Jayalakshmi K., Saravanan M., Ranjithkumar M., Sivakumar M., Selvaraj P. Technical Review on Inflammatory Bowel Disease in dogs and cats. Int. J. Sci. Environ. Technol. 2017;6:1833&#x2013;1842.</Citation></Reference><Reference><Citation>Allenspach K., Wieland B., Gr&#xf6;ne A., Gaschen F. Chronic Enteropathies in Dogs: Evaluation of Risk Factors for Negative Outcome. Vet. Intern. Medicne. 2007;21:700&#x2013;708. doi: 10.1111/j.1939-1676.2007.tb03011.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1939-1676.2007.tb03011.x</ArticleId><ArticleId IdType="pubmed">17708389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jergens A.E., Heilmann R.M. Canine Chronic Enteropathy&#x2014;Current State-of-the-Art and Emerging Concepts. Front. Vet. Sci. 2022;9:923013. doi: 10.3389/fvets.2022.923013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2022.923013</ArticleId><ArticleId IdType="pmc">PMC9534534</ArticleId><ArticleId IdType="pubmed">36213409</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchetti V., Gori E., Mariotti V., Gazzano A., Mariti C. The Impact of Chronic Inflammatory Enteropathy on Dogs&#x2019; Quality of Life and Dog-Owner Relationship. Vet. Sci. 2021;8:166. doi: 10.3390/vetsci8080166.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vetsci8080166</ArticleId><ArticleId IdType="pmc">PMC8402703</ArticleId><ArticleId IdType="pubmed">34437488</ArticleId></ArticleIdList></Reference><Reference><Citation>Allenspach K.A., Mochel J.P., Du Y., Priestnall S.L., Moore F., Slayter M. Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease. Vet. Pathol. 2019;56:435&#x2013;443. doi: 10.1177/0300985818813090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985818813090</ArticleId><ArticleId IdType="pubmed">30563436</ArticleId></ArticleIdList></Reference><Reference><Citation>Siel D., Beltr&#xe1;n C.J., Mart&#xed;nez E., Pino M., Vargas N., Salinas A., P&#xe9;rez O., Pereira I., Ram&#xed;rez-Toloza G. Elucidating the Role of Innate and Adaptive Immune Responses in the Pathogenesis of Canine Chronic Inflammatory Enteropathy&#x2014;A Search for Potential Biomarkers. Animals. 2022;12:1645. doi: 10.3390/ani12131645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ani12131645</ArticleId><ArticleId IdType="pmc">PMC9264988</ArticleId><ArticleId IdType="pubmed">35804545</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatiya-aphiradee N., Chatuphonprasert W., Jarukamjorn K. Immune response and inflammatory pathway of ulcerative colitis. J. Basic Clin. Physiol. Pharmacol. 2018;30:1&#x2013;10. doi: 10.1515/jbcpp-2018-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jbcpp-2018-0036</ArticleId><ArticleId IdType="pubmed">30063466</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath M.F. Current and emerging therapeutic targets for IBD. Nat. Rev. Gastroenterol. Hepatol. 2017;14:269&#x2013;278. doi: 10.1038/nrgastro.2016.208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2016.208</ArticleId><ArticleId IdType="pubmed">28144028</ArticleId></ArticleIdList></Reference><Reference><Citation>Jergens A.E., Sonea I.M., O&#x2019;Connor A.M., Kauffman L.K., Grozdanic S.D., Ackermann M.R., Evans R.B. Intestinal Cytokine mRNA Expression in Canine Inflammatory Bowel Disease: A Meta-Analysis with Critical Appraisal. Comp. Med. 2009;59:153&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703145</ArticleId><ArticleId IdType="pubmed">19389307</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilmann R.M., Suchodolski J.S. Is Inflammatory Bowel Disease in Dogs and Cats Associated with a Th1 or Th2 Polarization? Vet. Immunol. Immunopathol. 2015;168:131&#x2013;134. doi: 10.1016/j.vetimm.2015.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2015.10.008</ArticleId><ArticleId IdType="pubmed">26672910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta H., Takada K., Sunden Y., Tamura Y., Osuga T., Lim S.Y., Murakami M., Sasaki N., Wickramasekara Rajapakshage B.K., Nakamura K., et al. CD4+ T Cell Cytokine Gene and Protein Expression in Duodenal Mucosa of Dogs with Inflammatory Bowel Disease. J. Vet. Med. Sci. 2014;76:409&#x2013;414. doi: 10.1292/jvms.13-0008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.13-0008</ArticleId><ArticleId IdType="pmc">PMC4013368</ArticleId><ArticleId IdType="pubmed">24270804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz S., Garden O., Werling D., Allenspach K. Gene Expression of Selected Signature Cytokines of T Cell Subsets in Duodenal Tissues of Dogs with and without Inflammatory Bowel Disease. Vet. Immunol. Immunopathol. 2012;146:87&#x2013;91. doi: 10.1016/j.vetimm.2012.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2012.01.013</ArticleId><ArticleId IdType="pubmed">22333286</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura Y., Ohta H., Yokoyama N., Lim S.Y., Osuga T., Morishita K., Nakamura K., Yamasaki M., Takiguchi M. Evaluation of Selected Cytokine Gene Expression in Colonic Mucosa from Dogs with Idiopathic Lymphocytic-Plasmacytic Colitis. J. Vet. Med. Sci. 2014;76:1407&#x2013;1410. doi: 10.1292/jvms.13-0635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1292/jvms.13-0635</ArticleId><ArticleId IdType="pmc">PMC4221177</ArticleId><ArticleId IdType="pubmed">24976586</ArticleId></ArticleIdList></Reference><Reference><Citation>Marafini I., Sedda S., Dinallo V., Monteleone G. Inflammatory cytokines: From discoveries to therapies in IBD. Expert Opin. Biol. Ther. 2019;19:1207&#x2013;1217. doi: 10.1080/14712598.2019.1652267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14712598.2019.1652267</ArticleId><ArticleId IdType="pubmed">31373244</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaga C., Kakiyama S., Hokkyo A., Ogata Y., Shibata J., Nagahara T., Nakazawa M., Nakagawa T., Tsujimoto H., Chambers J.K., et al. Characterization of Faecal Microbiota and Serum Inflammatory Markers in Dogs Diagnosed with Chronic Enteropathy or Small-Cell Lymphoma: A Pilot Study. Sci. Rep. 2024;14:19387. doi: 10.1038/s41598-024-69923-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-69923-1</ArticleId><ArticleId IdType="pmc">PMC11339456</ArticleId><ArticleId IdType="pubmed">39169196</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes V., Galv&#xe3;o I., Vieira A.T. Mechanisms by Which the Gut Microbiota Influences Cytokine Production and Modulates Host Inflammatory Responses. J. Interferon Cytokine Res. 2019;39:393&#x2013;409. doi: 10.1089/jir.2019.0011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2019.0011</ArticleId><ArticleId IdType="pubmed">31013453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni N., Pathak M., Lal G. Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance. J. Leukoc. Biol. 2017;101:377&#x2013;394. doi: 10.1189/jlb.1RU0716-327R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1RU0716-327R</ArticleId><ArticleId IdType="pubmed">27899415</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda S., Ohno K., Nakamura K., Uchida K., Nakashima K., Fukushima K., Tsukamoto A., Goto-Koshino Y., Fujino Y., Tsujimoto H. Mucosal Imbalance of Interleukin-1&#x3b2; and Interleukin-1 Receptor Antagonist in Canine Inflammatory Bowel Disease. Vet. J. 2012;194:66&#x2013;70. doi: 10.1016/j.tvjl.2012.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tvjl.2012.02.026</ArticleId><ArticleId IdType="pubmed">22483380</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda S., Ohno K., Uchida K., Nakashima K., Fukushima K., Tsukamoto A., Nakajima M., Fujino Y., Tsujimoto H. Decreased Immunoglobulin A Concentrations in Feces, Duodenum, and Peripheral Blood Mononuclear Cells of Dogs with Inflammatory Bowel Disease. Vet. Intern. Medicne. 2013;27:47&#x2013;55. doi: 10.1111/jvim.12023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.12023</ArticleId><ArticleId IdType="pubmed">23216572</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva F., Rodrigues B.L., Ayrizono M.L., Leal R.F. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol. Res. Pract. 2016;2016:2097274. doi: 10.1155/2016/2097274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2097274</ArticleId><ArticleId IdType="pmc">PMC5192315</ArticleId><ArticleId IdType="pubmed">28070181</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis A.O., Adamama-Moraitou K.K., Pardali D., Dovas C.I., Brellou G.D., Papadopoulos T., Jergens A.E., Allenspach K., Rallis T.S. Colonic Mucosal and Cytobrush Sample Cytokine mRNA Expression in Canine Inflammatory Bowel Disease and Their Correlation with Disease Activity, Endoscopic and Histopathologic Score. PLoS ONE. 2021;16:e0245713. doi: 10.1371/journal.pone.0245713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0245713</ArticleId><ArticleId IdType="pmc">PMC7817028</ArticleId><ArticleId IdType="pubmed">33471872</ArticleId></ArticleIdList></Reference><Reference><Citation>Agulla B., Villaescusa A., Sainz &#xc1;., D&#xed;az-Rega&#xf1;&#xf3;n D., Rodr&#xed;guez-Franco F., Calleja-Bueno L., Olmeda P., Garc&#xed;a-Sancho M. Peripheral and Intestinal T Lymphocyte Subsets in Dogs with Chronic Inflammatory Enteropathy. Vet. Intern. Medicne. 2024;38:1437&#x2013;1448. doi: 10.1111/jvim.17036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jvim.17036</ArticleId><ArticleId IdType="pmc">PMC11099799</ArticleId><ArticleId IdType="pubmed">38472110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40465890</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-9849</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Revista da Sociedade Brasileira de Medicina Tropical</Title><ISOAbbreviation>Rev Soc Bras Med Trop</ISOAbbreviation></Journal><ArticleTitle>Cytogenetic Alterations Observed in Exfoliative Cells of the Tongue and Oral Mucosa of SARS-CoV-2-Vaccinated Patients: Report of Two Cases and a Brief Literature Review.</ArticleTitle><Pagination><StartPage>e008042025</StartPage><MedlinePgn>e008042025</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00804-2025</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/0037-8682-0008-2025</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0037-86822025000100804</ELocationID><Abstract><AbstractText>The wide distribution of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) in oral tissues, especially in the salivary glands, which are natural reservoirs of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), contributes to the classification of the oral cavity as a potential target for the development of lesions. Despite the effective response produced by next-generation immunizers, the possibility of immune escape by new lineages of SARS-CoV-2 cannot be refuted. Therefore, we describe here the occurrence of cytogenetic alterations in orally exfoliated cells of immunized individuals and, based on the literature review, call attention to the need to monitor these cases in the post-pandemic period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santana</LastName><ForeName>Lucas Alves da Mota</ForeName><Initials>LADM</Initials><Identifier Source="ORCID">0000-0002-8261-1504</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Michelly Kierkegaard Campos de</ForeName><Initials>MKC</Initials><Identifier Source="ORCID">0009-0003-6799-8151</Identifier><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Maria Vit&#xf3;ria Concei&#xe7;&#xe3;o</ForeName><Initials>MVC</Initials><Identifier Source="ORCID">0009-0003-7853-8759</Identifier><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moura</LastName><ForeName>Pedro Henrique Macedo</ForeName><Initials>PHM</Initials><Identifier Source="ORCID">0000-0002-5689-2090</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Farm&#xe1;cia, S&#xe3;o Crist&#xf3;v&#xe3;o, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreto</LastName><ForeName>Marina Dos Santos</ForeName><Initials>MDS</Initials><Identifier Source="ORCID">0000-0003-4724-0688</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Farm&#xe1;cia, S&#xe3;o Crist&#xf3;v&#xe3;o, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Marcos Ant&#xf4;nio Lima Dos</ForeName><Initials>MALD</Initials><Identifier Source="ORCID">0000-0002-7589-4809</Identifier><AffiliationInfo><Affiliation>Universidade de S&#xe3;o Paulo, Faculdade de Odontologia, Departamento de Estomatologia, S&#xe3;o Paulo, SP, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Pedro Lima Dos</ForeName><Initials>PLD</Initials><Identifier Source="ORCID">0009-0005-9057-8168</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departamento de Medicina, Laborat&#xf3;rio de Patologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correia</LastName><ForeName>Dalmo</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2174-5058</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Medicina, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Medicina, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Virg&#xed;nia Kelma Dos Santos</ForeName><Initials>VKDS</Initials><Identifier Source="ORCID">0000-0002-2777-8811</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopalsamy</LastName><ForeName>Rajiv Gandhi</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0003-4030-0879</Identifier><AffiliationInfo><Affiliation>Rajagiri College of Social Sciences, Division of Phytochemistry and Drug Design, Department of Biosciences, Kochi, Kerala, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trento</LastName><ForeName>Cleverson Luciano</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-1079-4217</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Odontologia, Aracaju, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Lysandro Pinto</ForeName><Initials>LP</Initials><Identifier Source="ORCID">0000-0002-1721-1547</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departmento de Farm&#xe1;cia, S&#xe3;o Crist&#xf3;v&#xe3;o, SE, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeshita</LastName><ForeName>Wilton Mitsunari</ForeName><Initials>WM</Initials><Identifier Source="ORCID">0000-0001-5682-1498</Identifier><AffiliationInfo><Affiliation>Universidade Estadual Paulista J&#xfa;lio de Mesquita Filho, Faculdade de Odontologia, Departamento de Diagn&#xf3;stico e Cirurgia, Ara&#xe7;atuba, SP, Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Soc Bras Med Trop</MedlineTA><NlmUniqueID>7507456</NlmUniqueID><ISSNLinking>0037-8682</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009061" MajorTopicYN="Y">Mouth Mucosa</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014059" MajorTopicYN="Y">Tongue</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002869" MajorTopicYN="Y">Chromosome Aberrations</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest: </b>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>15</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40465890</ArticleId><ArticleId IdType="pmc">PMC12129134</ArticleId><ArticleId IdType="doi">10.1590/0037-8682-0008-2025</ArticleId><ArticleId IdType="pii">S0037-86822025000100804</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sarker R, Roknuzzaman ASM, Hossain MJ, Bhuiyan MA, Islam MR. The WHO declares COVID-19 is no longer a public health emergency of international concern: benefits, challenges, and necessary precautions to come back to normal life. Int J Surg. 2023;109(9):2851&#x2013;2852. doi: 10.1097/JS9.0000000000000513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JS9.0000000000000513</ArticleId><ArticleId IdType="pmc">PMC10498846</ArticleId><ArticleId IdType="pubmed">37222700</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO)  COVID-19 epidemiological update. Dec 24, 2024.  [February 10, 2025].  Available from:  https://www.who.int/publications/m/item/covid-19-epidemiological-update---24-december-2024
.</Citation></Reference><Reference><Citation>Smarz-Widelska I, Grywalska E, Morawska I, Forma A, Michalski A, Mertowski S, et al. Pathophysiology and Clinical Manifestations of COVID-19-Related Acute Kidney Injury-The Current State of Knowledge and Future Perspectives. Int J Mol Sci. 2021;22(13):7082&#x2013;7082. doi: 10.3390/ijms22137082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22137082</ArticleId><ArticleId IdType="pmc">PMC8268979</ArticleId><ArticleId IdType="pubmed">34209289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Ma Y, Xu Y, Liu J, Li X, Chen Y, et al. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma. Emerg Microbes Infect. 2022;11(1):424&#x2013;427. doi: 10.1080/22221751.2022.2027219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2027219</ArticleId><ArticleId IdType="pmc">PMC8803103</ArticleId><ArticleId IdType="pubmed">35001836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L, Liu Q, Wang M, Li L, Hu Z, Zhou Y, et al. Severe acute respiratory syndrome coronavirus 2 pathology and cell tropism in tongue tissues of COVID-19 autopsies. Front Cell Infect Microbiol. 2024;14:1394721&#x2013;1394721. doi: 10.3389/fcimb.2024.1394721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2024.1394721</ArticleId><ArticleId IdType="pmc">PMC11224463</ArticleId><ArticleId IdType="pubmed">38975331</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana LADM, Vieira WA, Gon&#xe7;alo RIC, Lima Dos Santos MA, Takeshita WM, Miguita L. Oral mucosa lesions in confirmed and non-vaccinated cases for COVID-19: A systematic review. J Stomatol Oral Maxillofac Surg. 2022;123(5):e241-e250. doi: 10.1016/j.jormas.2022.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jormas.2022.05.005</ArticleId><ArticleId IdType="pmc">PMC9085350</ArticleId><ArticleId IdType="pubmed">35550190</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques BBF, Guimar&#xe3;es TC, Fischer RG, Tinoco JMM, Pires FR, Lima JC, Junior, et al. Morphological alterations in tongue epithelial cells infected by SARS-CoV-2: A case-control study. Oral Dis. 2022;28(Suppl 2):2417&#x2013;2422. doi: 10.1111/odi.13988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13988</ArticleId><ArticleId IdType="pmc">PMC8447065</ArticleId><ArticleId IdType="pubmed">34342110</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto TG, Alpire MES, Ribeiro DA. Cytogenetic Biomonitoring in Buccal Mucosa Cells of COVID-19 Patients: Preliminary Findings. In Vivo. 2021;35(6):3495&#x2013;3499. doi: 10.21873/invivo.12651.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12651</ArticleId><ArticleId IdType="pmc">PMC8627778</ArticleId><ArticleId IdType="pubmed">34697187</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva MM, Lucena ASL, Paiva SSL, J&#xfa;nior, Carvalho VMF, Oliveira PSS, Rosa MM, et al. Cell death mechanisms involved in cell injury caused by SARS-CoV-2. Rev Med Virol. 2022;32(3):e2292. doi: 10.1002/rmv.2292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2292</ArticleId><ArticleId IdType="pmc">PMC8646768</ArticleId><ArticleId IdType="pubmed">34590761</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H, Ma C, Peng H, Zhang B, Zhou L, Suet Y, et al. Micronucleus production, activation of DNA damage response and cGAS-STING signaling in syncytia induced by SARS-CoV-2 infection. 1Biol Direct. 2021;16:20&#x2013;20. doi: 10.1186/s13062-021-00305-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-021-00305-7</ArticleId><ArticleId IdType="pmc">PMC8530504</ArticleId><ArticleId IdType="pubmed">34674770</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Saleh H, Abo-Halawa BY, Younes S, Younes N, Al-Sadeq DW, Shurrabet FM, et al. Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection. J Travel Med. 2022;29(8):taac130&#x2013;taac130. doi: 10.1093/jtm/taac130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taac130</ArticleId><ArticleId IdType="pmc">PMC9793397</ArticleId><ArticleId IdType="pubmed">36342115</ArticleId></ArticleIdList></Reference><Reference><Citation>Boretti A. mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review. Clin Exp Med. 2024;24(1):23&#x2013;23. doi: 10.1007/s10238-023-01264-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01264-1</ArticleId><ArticleId IdType="pmc">PMC10821957</ArticleId><ArticleId IdType="pubmed">38280109</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40014816</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1852-4834</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta odontologica latinoamericana : AOL</Title><ISOAbbreviation>Acta Odontol Latinoam</ISOAbbreviation></Journal><ArticleTitle>Subgingival biofilm colonization by Candida albicans and Candida dubliniensis in patients living with HIV from Buenos Aires, Argentina.</ArticleTitle><Pagination><StartPage>191</StartPage><EndPage>202</EndPage><MedlinePgn>191-202</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.54589/aol.37/3/191</ELocationID><Abstract><AbstractText Label="UNLABELLED">Oropharyngeal candidiasis (OC) is common among people living with HIV (PLWH). Persistent colonization of oral epithelial surfaces serves as an ecological niche for opportunistic pathogens and is a significant predisposing factor for OC development in PLWH. Mucosal colonization can lead to biofilm formation, directly impacting oral epithelium.</AbstractText><AbstractText Label="AIM">To assess Candida albicans and Candida dubliniensis colonization in subgingival biofilms of people living with HIV (PLWH) and undergoing antiretroviral therapy (ART).</AbstractText><AbstractText Label="MATERIALS AND METHOD">A sample of 51 PLWH who were receiving ART was studied, focusing on dental and periodontal parameters. Subgingival biofilm and mucosa samples were collected, and Candida spp. were identified using molecular techniques.</AbstractText><AbstractText Label="RESULTS">Men (average age: 41.11 &#xb1; 8.63) predominated. The main cause of HIV was sexual transmission. Fungal-related opportunistic diseases were observed in 18 patients, and LT CD4 counts were evaluated. A total 255 samples were collected, including 204 from gingivoperiodontal sites and 51 from oral mucosa. Candida spp. was detected in 55% of patients, with particular distribution patterns. Positive Candida spp. presence correlated with clinical attachment level and HIV treatments. Microscopic identification revealed the presence of hyphae at the time of microbiological sample collection. Molecular identification confirmed 16 Candida albicans and 36 Candida dubliniensis isolates, challenging their diagnostic importance.</AbstractText><AbstractText Label="CONCLUSIONS">The presence of yeast hyphae/pseudohyphae in subgingival biofilms indicates their role in gingivo-periodontal disease dysbiosis. PLWH in this Argentine region face challenges including limited access to healthcare. The study underscores the need for early oral health intervention, emphasizing the diagnostic significance of Candida.</AbstractText><CopyrightInformation>Copyright&#xa9; 2024 Sociedad Argentina de Investigaci&#xf3;n Odontol&#xf3;gica.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dubois</LastName><ForeName>Ver&#xf3;nica &#xc1;</ForeName><Initials>V&#xc1;</Initials><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - C&#xe1;tedra de Microbiolog&#xed;a y Parasitolog&#xed;a, Laboratorio de Diagn&#xf3;stico Microbiol&#xf3;gico y Molecular. Buenos Aires - Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - Instituto de Investigaciones en Salud P&#xfa;blica (IISAP). Buenos Aires - Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salgado</LastName><ForeName>Pablo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - C&#xe1;tedra de Microbiolog&#xed;a y Parasitolog&#xed;a, Laboratorio de Diagn&#xf3;stico Microbiol&#xf3;gico y Molecular. Buenos Aires - Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - Instituto de Investigaciones en Salud P&#xfa;blica (IISAP). Buenos Aires - Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - C&#xe1;tedra de Odontolog&#xed;a Preventiva y Comunitaria, Buenos Aires - Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molgatini</LastName><ForeName>Susana L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - C&#xe1;tedra de Microbiolog&#xed;a y Parasitolog&#xed;a, Laboratorio de Diagn&#xf3;stico Microbiol&#xf3;gico y Molecular. Buenos Aires - Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - Instituto de Investigaciones en Salud P&#xfa;blica (IISAP). Buenos Aires - Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gliosca</LastName><ForeName>Laura A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - C&#xe1;tedra de Microbiolog&#xed;a y Parasitolog&#xed;a, Laboratorio de Diagn&#xf3;stico Microbiol&#xf3;gico y Molecular. Buenos Aires - Argentina, laura.gliosca@odontologia.uba.ar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad de Buenos Aires - Facultad de Odontolog&#xed;a - Instituto de Investigaciones en Salud P&#xfa;blica (IISAP). Buenos Aires - Argentina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>01-02-18</GrantID><Agency>Facultad de Odontolog&#xed;a de la Universidad de Buenos Aires, Programa de apoyo a la Investigaci&#xf3;n Integrada CONVOCATORIA 2019 -2024</Agency><Country/></Grant><Grant><GrantID>UBACYT 20720160100002BA</GrantID><Agency>University of Buenos Aires</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Argentina</Country><MedlineTA>Acta Odontol Latinoam</MedlineTA><NlmUniqueID>8610218</NlmUniqueID><ISSNLinking>0326-4815</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018441" MajorTopicYN="Y">Biofilms</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002176" MajorTopicYN="Y">Candida albicans</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002175" MajorTopicYN="Y">Candida</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="Y">HIV Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002180" MajorTopicYN="Y">Candidiasis, Oral</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005881" MajorTopicYN="Y">Gingiva</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="UNLABELLED">La candidiasis orofar&#xed;ngea (CO) es com&#xfa;n en pacientes que viven con HIV (PVVS). La colonizaci&#xf3;n persistente de las superficies epiteliales orales sirve como reservorio para pat&#xf3;genos oportunistas. Esta colonizaci&#xf3;n es un factor predisponente para el desarrollo de la CO en PVVS. La colonizaci&#xf3;n mucosa puede llevar a la formaci&#xf3;n de biofilm, impactando directamente en el epitelio oral.</AbstractText><AbstractText Label="OBJETIVO">Evaluar la colonizaci&#xf3;n por Candida albicans y Candida dubliniensis en biofilm subgingival de pacientes que viven con VIH (PVVS) bajo tratamiento antirretroviral.</AbstractText><AbstractText Label="MATERIALES Y M&#xc9;TODO">Se estudi&#xf3; una cohorte de 51 PVVS bajo TAR, centr&#xe1;ndose en par&#xe1;metros dentales y periodontales. Se recolectaron muestras de biofilm subgingival y mucosa, identificando Candida spp. mediante t&#xe9;cnicas moleculares.</AbstractText><AbstractText Label="RESULTADOS">Predominaron hombres con edad promedio de 41,11 &#xb1; 8,63, siendo la transmisi&#xf3;n sexual la principal v&#xed;a. Se observaron enfermedades oportunistas relacionadas con hongos en 18 pacientes, evalu&#xe1;ndose los recuentos de CD4 a largo plazo. En total, se recopilaron 255 muestras, incluyendo 204 de sitios gingivo-periodontales y 51 de mucosa oral. Se detect&#xf3; Candida spp. en el 55% de los pacientes, con patrones de distribuci&#xf3;n particular. La presencia positiva de Candida spp. se correlacion&#xf3; con nivel de inserci&#xf3;n cl&#xed;nica y TAR. La identificaci&#xf3;n microsc&#xf3;pica revel&#xf3; la presencia de hifas al momento de la toma de muestras microbiol&#xf3;gicas. La identificaci&#xf3;n molecular confirm&#xf3; 16 aislamientos de Candida albicans y 36 de Candida dubliniensis, desafiando su importancia diagn&#xf3;stica.</AbstractText><AbstractText Label="CONCLUSIONES">La presencia de hifas/pseudohifas de levaduras en biofilm subgingival indica su papel en la disbiosis de enfermedades gingivo-periodontales. Los PVVS en esta regi&#xf3;n argentina enfrentan desaf&#xed;os debido al acceso m&#xe9;dico limitado. El estudio destaca la necesidad de intervenciones tempranas en la salud oral, enfatizando la importancia diagn&#xf3;stica de Candida spp.</AbstractText><CopyrightInformation>Copyright&#xa9; 2024 Sociedad Argentina de Investigaci&#xf3;n Odontol&#xf3;gica.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Candida albicans</Keyword><Keyword MajorTopicYN="N">Candida dubliniensis</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">oral colonization</Keyword><Keyword MajorTopicYN="N">periodontitis</Keyword><Keyword MajorTopicYN="N">subgingival biofilm</Keyword></KeywordList><CoiStatement>The authors declare no potential conflicts of interest regarding the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>18</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>27</Day><Hour>15</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40014816</ArticleId><ArticleId IdType="pmc">PMC12324076</ArticleId><ArticleId IdType="doi">10.54589/aol.37/3/191</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lourenjo AG, Ribeiro AERA, Nakao C, Motta ACF, et al. Oral Candida spp carriage and periodontal diseases in HlV-infected patients in Ribeirao Preto, Brazil . Rev Inst Med Trop Sao Paulo. 2017;59:29. doi: 10.1590/S1678-9946201759029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946201759029</ArticleId><ArticleId IdType="pmc">PMC5459536</ArticleId><ArticleId IdType="pubmed">28591257</ArticleId></ArticleIdList></Reference><Reference><Citation>Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults
and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic
Infections in Adults and Adolescents with HIV
. National Institutes of Health, Centers for Disease Control and Prevention, HIV
Medicine Association, and Infectious Diseases Society of America
; 2023. Jan 1, 
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
</Citation></Reference><Reference><Citation>Li Y, Saxena D, Chen Z, Liu G, et al. HIV infection and microbial diversity in saliva. J Clin Microbiol. 2014;52:1400&#x2013;11. doi: 10.1128/jcm.02954-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.02954-13</ArticleId><ArticleId IdType="pmc">PMC3993673</ArticleId><ArticleId IdType="pubmed">24523469</ArticleId></ArticleIdList></Reference><Reference><Citation>Paula SB, Morey AT, Santos JP, Santos PM, et al. Oral Candida colonization in HIV-infected patients in Londrina-PR, Brazil: antifungal susceptibility and virulence factors . J Infect Dev Ctries. 2015;1350:9. doi: 10.3855/jidc.6970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.6970</ArticleId><ArticleId IdType="pubmed">26719941</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittayananta W, Tao R, Jiang L, Peng Y, et al. Oral innate immunity in HIV infection in HAART era. J Oral Pathol Med. 2016;45:3&#x2013;8. doi: 10.1111/jop.12304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jop.12304</ArticleId><ArticleId IdType="pmc">PMC4671827</ArticleId><ArticleId IdType="pubmed">25639844</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes R de P, Borges AS, Araujo LB, Pedroso Rdos S, et al. Related factors for colonization by Candida species in the oral cavity of HIV-Infected individuals . Rev Inst Med Trop Sao Paulo. 2015;57:413&#x2013;9. doi: 10.1590/S0036-46652015000500008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0036-46652015000500008</ArticleId><ArticleId IdType="pmc">PMC4660451</ArticleId><ArticleId IdType="pubmed">26603229</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois VA, Gonz&#xe1;lez MI, Mart&#xed;nez ME, Fedelli L, et al. Enzyme production by Candida albicans and Candida dubliniensis in periodontal HIV-positive patients receiving and not receiving antiretroviral therapy . Acta Odontol Latinoam. 2020;33:104&#x2013;11. doi: 10.54589/aol.33/2Z104.</Citation><ArticleIdList><ArticleId IdType="doi">10.54589/aol.33/2Z104</ArticleId><ArticleId IdType="pubmed">32920612</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyes DL, Richardson JP, Naglik JR. Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface . Virulence. 2015;6:338&#x2013;46. doi: 10.1080/21505594.2015.1012981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2015.1012981</ArticleId><ArticleId IdType="pmc">PMC4601190</ArticleId><ArticleId IdType="pubmed">25714110</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YY, Chen WY, Li X, Li HB, et al. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China . BMC Infect Dis. 2013;28:13&#x2013;46. doi: 10.1186/1471-2334-13-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-13-46</ArticleId><ArticleId IdType="pmc">PMC3641955</ArticleId><ArticleId IdType="pubmed">23356471</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg A, Tugizov S, Pandiyan P, Jin G, et al. Innate immune mechanisms to oral pathogens in oral mucosa of HIV-infected individuals . Oral Dis. 2020;26:69&#x2013;79. doi: 10.1111/odi.13470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.13470</ArticleId><ArticleId IdType="pmc">PMC7570967</ArticleId><ArticleId IdType="pubmed">32862519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaongo SD, Ouyang J, Isnard S, Zhou X, et al. Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection . Gut Microbes. 2023;15:2167171. doi: 10.1080/19490976.2023.2167171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2167171</ArticleId><ArticleId IdType="pmc">PMC9897780</ArticleId><ArticleId IdType="pubmed">36722096</ArticleId></ArticleIdList></Reference><Reference><Citation>Cern&#xe1;kov&#xe1; L, Rodrigues CF. Microbial interactions and immunity response in oral Candida species . Future Microbiol. 2020;15:1653&#x2013;1677. doi: 10.2217/fmb-2020-0113.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2020-0113</ArticleId><ArticleId IdType="pubmed">33251818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, et al. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals . Microbiology (Reading) 1995;141:1507&#x2013;21. doi: 10.1099/13500872-141-7-1507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/13500872-141-7-1507</ArticleId><ArticleId IdType="pubmed">7551019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabra-Rizk MA, Ferreira SM, Sabet M, Falkler WA, et al. Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions . J Clin Microbiol. 2001;39:4520&#x2013;2. doi: 10.1128/jcm.39.12.4520-4522.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jcm.39.12.4520-4522.2001</ArticleId><ArticleId IdType="pmc">PMC88577</ArticleId><ArticleId IdType="pubmed">11724873</ArticleId></ArticleIdList></Reference><Reference><Citation>Price C, Wilson I, Catchpoole E. Candida dubliniensis chronic meningitis in an immunocompetent patient: Case report and literature review . IDCases. 2022;31:e01665. doi: 10.1016/jidcr.2022.e01665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jidcr.2022.e01665</ArticleId><ArticleId IdType="pmc">PMC9801098</ArticleId><ArticleId IdType="pubmed">36589766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakehi A, Hagiya H, Iio K, Nakano Y, et al. Candida dubliniensis fungemia in a patient with severe COVID-19: A case report . J Infect Chemother. 2022;28:1433&#x2013;1435. doi: 10.1016/jjiac.2022.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/jjiac.2022.07.007</ArticleId><ArticleId IdType="pmc">PMC9293379</ArticleId><ArticleId IdType="pubmed">35863730</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafroodifar A, Thibodeau R, Scalzetti E. Candida dubliniensis Fungemia Leading to Infective Endocarditis and Septic Pulmonary Emboli . Cureus. 2023;15:e39031. doi: 10.7759/cureus.39031.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.39031</ArticleId><ArticleId IdType="pmc">PMC10266299</ArticleId><ArticleId IdType="pubmed">37323365</ArticleId></ArticleIdList></Reference><Reference><Citation>Papapanou PN, Sanz M, Buduneli N, Dietrich T, et al. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions . J Periodontol. 2018;89:S173&#x2013;S182. doi: 10.1002/JPER.17-0721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.17-0721</ArticleId><ArticleId IdType="pubmed">29926951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition . J Clin Periodontol. 2018;45:S149&#x2013;S161. doi: 10.1111/jcpe.12945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpe.12945</ArticleId><ArticleId IdType="pubmed">29926495</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliosca LA, D&#x2019;Eramo LR, Bozza FL, Soken L, et al.  Microbiological study of the subgingival biofilm in HIV + /HAART patients at a
specialized dental service
. Acta Odontol Latinoam. 2019;32:147&#x2013;55. 
https://actaodontologicalat.com/wp-content/uploads/2020/03/aol_2019_32_3_147.pdf
</Citation><ArticleIdList><ArticleId IdType="pubmed">32176238</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois VA, Salgado PA, Gliosca LA, Molgatini SL. gDNA extraction from Candida albicans and Candida dubliniensis in subgingival samples in Argentina. Evaluation of different methods . Acta Odontol Latinoam. 2023;36:78&#x2013;85. doi: 10.54589/aol.36/2/78.</Citation><ArticleIdList><ArticleId IdType="doi">10.54589/aol.36/2/78</ArticleId><ArticleId IdType="pmc">PMC10557081</ArticleId><ArticleId IdType="pubmed">37776504</ArticleId></ArticleIdList></Reference><Reference><Citation>Padovan AC, Chaves GM, Colombo AL, Briones MR. A novel allele of HWP1, isolated from a clinical strain of Candida albicans with defective hyphal growth and biofilm formation, has deletions of Gln/Pro and Ser/Thr repeats involved in cellular adhesion . Med Mycol. 2009;47:824&#x2013;35. doi: 10.3109/13693780802669574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13693780802669574</ArticleId><ArticleId IdType="pubmed">19184714</ArticleId></ArticleIdList></Reference><Reference><Citation>Respuesta al VIH y las ITS en la Argentina. Bolet&#xed;n. 
www.argentina.gob.ar/sites/default/files/bancos/2022-11/Sintesis_Boletin_N_39_de_Respuesta_al_VIH_y_las_ITS_en_Argentina.pdf
</Citation></Reference><Reference><Citation>HIV and AIDS. Jul, 2023. 
https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids
</Citation></Reference><Reference><Citation>Shintani T, Fujii T, Yamasaki N, Kitagawa M, et al. Oral environment and taste function of Japanese HIV-infected patients treated with antiretroviral therapy . AIDS Care. 2020;32:829&#x2013;834. doi: 10.1080/09540121.2019.1656327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09540121.2019.1656327</ArticleId><ArticleId IdType="pubmed">31426660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonjalves LS, de Carvalho Ferreira D, Vidal F, et al. Stage II and stage III periodontitis clinical burdens of HIV-1 undergoing antiretroviral therapy . Clin Oral Investig. 2022;26:2187&#x2013;2195. doi: 10.1007/s00784-021-04201-2. Erratum in: Clin Oral Investig. 2022; 26:4239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-021-04201-2</ArticleId><ArticleId IdType="pmc">PMC8487450</ArticleId><ArticleId IdType="pubmed">34601633</ArticleId></ArticleIdList></Reference><Reference><Citation>Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of
Antiretroviral Agents in Adults and Adolescents with HIV
. Department of Health and Human Services;  [Accessed (Octubre 2023)
]. 
https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new
</Citation></Reference><Reference><Citation>Annavajhala MK, Khan SD, Sullivan SB, Shah J, et al. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV onAntiretroviral Therapy . mSphere. 2020;5:e00798&#x2013;19. doi: 10.1128/msphere.00798-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/msphere.00798-19</ArticleId><ArticleId IdType="pmc">PMC7002309</ArticleId><ArticleId IdType="pubmed">32024712</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira LL, Veiga Siqueira Amorim D, Brito Sampaio W, Almeida Cruz Azevedo T, et al. Factors Associated with Periodontitis in Patients with and without HIV . Int J Dent. 2023;2023:9929835. doi: 10.1155/2023/9929835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/9929835</ArticleId><ArticleId IdType="pmc">PMC10163962</ArticleId><ArticleId IdType="pubmed">37159593</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf3;lvora TLS, Nobre &#xc1;VV, Tirapelli C, Taba M Jr, et al. Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis . Expert Rev Clin Immunol. 2018;14:315&#x2013;327. doi: 10.1080/1744666X.2018.1459571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2018.1459571</ArticleId><ArticleId IdType="pubmed">29595347</ArticleId></ArticleIdList></Reference><Reference><Citation>Phiri R, Feller L, Blignaut E. The severity, extent and recurrence of necrotizing periodontal disease in relation to HIV status and CD4+ T cell count . J Int Acad Periodontol. 2010;12:98&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">21128527</ArticleId></ArticleIdList></Reference><Reference><Citation>Sereme Y, P&#xf3;lvora TLS, Rochereau N, Teixeira LR, et al. Gingival tissue as a reservoir for human immunodeficiency virus type 1: Preliminary results of a cross-sectional observational study . J Periodontol. 2022;93:613&#x2013;620. doi: 10.1002/JPER.21-0345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.21-0345</ArticleId><ArticleId IdType="pubmed">34396525</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Su B, He QS, Wu H, et al. Alterations in the oral microbiome in HIV infection: causes, effects and potential interventions . Chin Med J. 2021;134:2788&#x2013;2798. doi: 10.1097/CM9.0000000000001825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000001825</ArticleId><ArticleId IdType="pmc">PMC8667981</ArticleId><ArticleId IdType="pubmed">34670249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushi MF, Mtemisika CI, Bader O, Bii C, et al. High Oral Carriage of Non-albicans Candida spp. among HIV-infected individuals . Int J Infect Dis. 2016;49:185&#x2013;188. doi: 10.1016/j.ijid.2016.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2016.07.001</ArticleId><ArticleId IdType="pubmed">27401585</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski dos santos Bruna, Santos Roca Lilian, Pedra Dias Eliane. There is an association between colonization by Candida spp. and periodontal disease - results of a systematic review . Rev. Bras. Odontol. 2018;75:e1368. doi: 10.18502/cmm.6.2.3420.</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/cmm.6.2.3420</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan G, Uppoor A, Naik D, Kadkampally D, et al. Oral Candida Carriage and Morphotype Differentiation in Chronic Periodontitis Patients with and without Diabetes in the Indian Sub-Continent . Dent J (Basel) 2015;3:123&#x2013;131. doi: 10.3390/dj3040123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/dj3040123</ArticleId><ArticleId IdType="pmc">PMC5851191</ArticleId><ArticleId IdType="pubmed">29567932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan D, Coleman D. Candida dubliniensis: characteristics and identification . J Clin Microbiol. 1998;36:329&#x2013;34. doi: 10.1128/JCM.36.2.329-334.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.36.2.329-334.1998</ArticleId><ArticleId IdType="pmc">PMC104537</ArticleId><ArticleId IdType="pubmed">9466736</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on . FEMS Microbiol Lett. 2005;253:9&#x2013;17. doi: 10.1016/j.femsle.2005.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.femsle.2005.09.015</ArticleId><ArticleId IdType="pubmed">16213674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngouana TK, Krasteva D, Drakulovski P, Toghueo RK, et al. Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaound&#xe9; (Cameroon) HIV-infected patients . Mycoses. 2015;58:33&#x2013;9. doi: 10.1111/myc.12266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/myc.12266</ArticleId><ArticleId IdType="pubmed">25289589</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancera E, Frazer C, Porman AM, Ruiz-Castro S, et al. Genetic Modification of Closely Related Candida Species . Front Microbiol. 2019;10:357. doi: 10.3389/fmicb.2019.00357. Erratum in: Front Microbiol. 2020; 11:713.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.00357</ArticleId><ArticleId IdType="pmc">PMC6433835</ArticleId><ArticleId IdType="pubmed">30941104</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhtar N, Magdaleno JSL, Ranjan S, Wani AK, et al. Secreted Aspartyl Proteinases Targeted Multi-Epitope Vaccine Design for Candida dubliniensis Using Immunoinformatics . Vaccines (Basel) 2023;11:364. doi: 10.3390/vaccines11020364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11020364</ArticleId><ArticleId IdType="pmc">PMC9964391</ArticleId><ArticleId IdType="pubmed">36851241</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MW, Singh N, Ng KF, Lam DK, et al. Inter-personal diversity and temporal dynamics of dental, tongue, and salivary microbiota in the healthy oral cavity . NPJ Biofilms Microbiomes. 2017;26:3&#x2013;2. doi: 10.1038/s41522-016-0011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-016-0011-0</ArticleId><ArticleId IdType="pmc">PMC5445578</ArticleId><ArticleId IdType="pubmed">28649403</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Song B, Brandt BW, Cheng L, et al. Comparison of Red-Complex Bacteria Between Saliva and Subgingival Plaque of Periodontitis Patients: A Systematic Review and Meta-Analysis . Front Cell Infect Microbiol. 2021;8:11&#x2013;727732. doi: 10.3389/fcimb.2021.727732.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.727732</ArticleId><ArticleId IdType="pmc">PMC8531218</ArticleId><ArticleId IdType="pubmed">34692561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39542542</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2448-5667</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Revista medica del Instituto Mexicano del Seguro Social</Title><ISOAbbreviation>Rev Med Inst Mex Seguro Soc</ISOAbbreviation></Journal><ArticleTitle>[Hyperthermia on colorectal cancer: gold nanoshells-mediated photothermal therapy].</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>8</EndPage><MedlinePgn>1-8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5954</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.5281/zenodo.11397181</ELocationID><Abstract><AbstractText>Colon cancer or colorectal cancer is one of the most common malignant neoplasms in the world, characterized by uncontrolled cell growth on the colon mucosa. Treatment approaches depend primarily on the characteristics of the tumor&#xb4;s localization, size, metastasis, and the health status of the patient. Nanomedicine shows itself as a novelty strategy to overcome the limitations of the therapies used in the clinic due to the disregard of the mechanisms associated with multidrug resistance because of the nanometric size of the particles utilized. Gold nanoshells are spheric structures of an approximate size of 30 nm, coated with an ultrathin gold layer that can absorb near-infrared light and convert it to thermal energy to produce hyperthermia on in vivo models of cancer tumors. Nanoparticles-assisted hyperthermia consists of control, direct, and specific heating against the tumor cells by nanoparticle irradiation with an external power source capable of increasing temperature to 39&#xb0;C - 45&#xb0;C without damaging surrounding healthy tissue. Compared with other nanomaterials, gold nanoshells show high biocompatibility and low cytotoxicity, which is why adjuvant chemotherapy and hyperthermia on gold nanoshells is a novel and promising approach for the treatment of colorectal cancer.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2024 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ochoa-Hugo</LastName><ForeName>Sarah Eliuth</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0000-0003-2964-4208</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco, Unidad de Biotecnolog&#xed;a M&#xe9;dica y Farmac&#xe9;utica, Laboratorio de Investigaci&#xf3;n Traslacional de Terapias contra el C&#xe1;ncer. Guadalajara, Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guti&#xe9;rrez-Mercado</LastName><ForeName>Yanet Karina</ForeName><Initials>YK</Initials><Identifier Source="ORCID">0000-0002-7358-054Xb</Identifier><AffiliationInfo><Affiliation>Universidad de Guadalajara, Centro Universitario de los Altos, Departamento de Cl&#xed;nicas, Laboratorio Biotecnol&#xf3;gico de Investigaci&#xf3;n y Diagn&#xf3;stico. Tepatitl&#xe1;n, Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canales-Aguirre</LastName><ForeName>Alejandro Arturo</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-0918-788X c</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco, Unidad de Biotecnolog&#xed;a M&#xe9;dica y Farmac&#xe9;utica, Unidad de Ensayos Precl&#xed;nicos. Guadalajara, Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Guti&#xe9;rrez</LastName><ForeName>Rodolfo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7566-6825d</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n y Asistencia en Tecnolog&#xed;a y Dise&#xf1;o del Estado de Jalisco, Unidad de Biotecnolog&#xed;a M&#xe9;dica y Farmac&#xe9;utica, Laboratorio de Investigaci&#xf3;n Traslacional de Terapias contra el C&#xe1;ncer. Guadalajara, Jalisco, M&#xe9;xico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType></PublicationTypeList><VernacularTitle>Hipertermia en c&#xe1;ncer de colon: terapia fotot&#xe9;rmica con nanocorazas de oro.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Rev Med Inst Mex Seguro Soc</MedlineTA><NlmUniqueID>101243727</NlmUniqueID><ISSNLinking>0443-5117</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7440-57-5</RegistryNumber><NameOfSubstance UI="D006046">Gold</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006046" MajorTopicYN="Y">Gold</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057145" MajorTopicYN="Y">Nanoshells</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082703" MajorTopicYN="Y">Photothermal Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006979" MajorTopicYN="Y">Hyperthermia, Induced</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>El c&#xe1;ncer de colon es una de las neoplasias malignas m&#xe1;s comunes en el mundo, caracterizada por un crecimiento descontrolado de las c&#xe9;lulas de la mucosa del colon, cuyo tratamiento depende de las caracter&#xed;sticas propias del tumor tales como su localizaci&#xf3;n, tama&#xf1;o, extensi&#xf3;n de met&#xe1;stasis y el estado de salud del paciente. La nanomedicina se muestra como una nueva estrategia para superar las limitaciones de las terapias actuales ya que debido al tama&#xf1;o nanom&#xe9;trico de los materiales empleados, estos pueden ignorar los mecanismos asociados a la resistencia multif&#xe1;rmaco. Las nanocorazas de oro poseen la capacidad de absorber luz infrarroja cercana y convertirla en energ&#xed;a t&#xe9;rmica para producir hipertermia en tumores in vivo. Esto se lleva a cabo mediante la metodolog&#xed;a de hipertermia asistida por nanopart&#xed;culas, la cual consiste en realizar irradiaci&#xf3;n a las nanopart&#xed;culas con una fuente de energ&#xed;a externa que produzca calor entre los 39 - 45 &#xb0;C, lo que genera un calentamiento controlado, dirigido y espec&#xed;fico contra el tumor sin da&#xf1;ar el tejido sano circundante. En comparaci&#xf3;n con otros nanomateriales, las nanocorazas de oro presentan alta biocompatibilidad y baja citotoxicidad. Por lo que, la terapia en combinaci&#xf3;n con quimioterap&#xe9;uticos m&#xe1;s hipertermia sobre nanocorazas de oro, se presenta como un enfoque novedoso y prometedor para el tratamiento del c&#xe1;ncer de colon.</AbstractText><CopyrightInformation>Licencia CC 4.0 (BY-NC-ND) &#xa9; 2024 Revista M&#xe9;dica del Instituto Mexicano del Seguro Social.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal Neoplasms</Keyword><Keyword MajorTopicYN="N">Hyperthermia</Keyword><Keyword MajorTopicYN="N">Nanoparticles</Keyword></KeywordList><CoiStatement>los autores han completado y enviado la forma traducida al espa&#xf1;ol de la declaraci&#xf3;n de conflictos potenciales de inter&#xe9;s del Comit&#xe9; Internacional de Editores de Revistas M&#xe9;dicas, y no fue reportado alguno que tuviera relaci&#xf3;n con este art&#xed;culo.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>16</Day><Hour>22</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>14</Day><Hour>21</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39542542</ArticleId><ArticleId IdType="pmc">PMC12360827</ArticleId><ArticleId IdType="doi">10.5281/zenodo.11397181</ArticleId><ArticleId IdType="pii">e5954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538338</ArticleId></ArticleIdList></Reference><Reference><Citation>Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325:669&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">33591350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawicki T, et al. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel) 2021;13:2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8122718</ArticleId><ArticleId IdType="pubmed">33922197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler M, et al. Colorectal Cancer. Abeloff&#x2019;s Clinical Oncology. 2020:1219&#x2013;1280.e15. doi: 10.1016/B978-0-323-47674-4.00074-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-47674-4.00074-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Brar B, et al. Nanotechnology in Colorectal Cancer for Precision Diagnosis and Therapy. Frontiers in Nanotechnology. 2021;3:66</Citation></Reference><Reference><Citation>Hossain Md S, et al. Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers (Basel) 2022;14:1732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996939</ArticleId><ArticleId IdType="pubmed">35406504</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman R, Chowdhry A, Lee V, Pappas L. Tratamiento del c&#xe1;ncer de colon - NCI. Instituto Nacional del C&#xe1;ncer (NCI)  Disponible en: https://www.cancer.gov/espanol/tipos/colorrectal/pro/tratamiento-colorrectal-pdq#_105 .</Citation></Reference><Reference><Citation>Alzahrani SM, Al Doghaither HA, Al-Ghafar AB. General insight into cancer: An overview of colorectal cancer (review) Mol Clin Oncol. 2021;15:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591689</ArticleId><ArticleId IdType="pubmed">34790355</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrecillas-Torres L, et al. Recomendaciones para diagn&#xf3;stico y tratamiento del c&#xe1;ncer de colon y recto en M&#xe9;xico. Gac Mex Oncol. 2019;18:265&#x2013;327.</Citation></Reference><Reference><Citation>Sobrero A, Bennicelli E. Chemotherapy: which drug and when? Ann Oncol. 2010;21:vii130&#x2013;vii133.</Citation><ArticleIdList><ArticleId IdType="pubmed">20943605</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie YH, Chen YX, Fang JY. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduct Target Ther. 2020;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7082344</ArticleId><ArticleId IdType="pubmed">32296018</ArticleId></ArticleIdList></Reference><Reference><Citation>Emran T Bin, et al. Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Front Oncol. 2022;12:891652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262248</ArticleId><ArticleId IdType="pubmed">35814435</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe1;rmol I, Quero J, Rodr&#xed;guez-Yoldi MJ, Cerrada E. Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment. Cancers (Basel) 2019 doi: 10.3390/cancers11060780.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11060780</ArticleId><ArticleId IdType="pmc">PMC6628079</ArticleId><ArticleId IdType="pubmed">31195711</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza L, et al. Nanoparticles in Colorectal Cancer Therapy: Latest in vivo Assays, Clinical Trials, and Patents. AAPS PharmSciTech. 2020;21:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32591920</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy AJ, Tunnell JW. Combinatorial immunotherapy and nanoparticle mediated hyperthermia. Adv Drug Deliv Rev. 2017;114:175&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">28625829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim&#xf3;n M, Norregaard K, J&#xf8;rgensen JT, Oddershede LB, Kjaer A. Fractionated photothermal therapy in a murine tumor model: Comparison with single dose. Int J Nanomedicine. 2019;14:5369&#x2013;5379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6645692</ArticleId><ArticleId IdType="pubmed">31409993</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrosa P, Vinhas R, Fernandes A, Baptista PV. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool? Nanomaterials (Basel) 2015;5:1853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5304792</ArticleId><ArticleId IdType="pubmed">28347100</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RS, Day ES. Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5474189</ArticleId><ArticleId IdType="pubmed">28160445</ArticleId></ArticleIdList></Reference><Reference><Citation>Libutti SK, et al. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine. Clin Cancer Res. 2010;16:6139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3004980</ArticleId><ArticleId IdType="pubmed">20876255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharlamov AN, et al. Silica-gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial. Nanoscale. 2015;7:8003&#x2013;8015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25864858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Zhao T, Han F, Hu Y, Li Y. Photothermal and gene therapy combined with immunotherapy to gastric cancer by the gold nanoshell-based system. J Nanobiotechnology. 2019;17</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612092</ArticleId><ArticleId IdType="pubmed">31277667</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubaj T, et al. Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro&#x2014;in vivo Correlation. Nanomaterials (Basel) 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8838925</ArticleId><ArticleId IdType="pubmed">35159859</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y, et al. Two-dimensional Hyper-branched Gold Nanoparticles Synthesized on a Two-dimensional Oil/Water Interface. Sci Rep. 2014;4:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143794</ArticleId><ArticleId IdType="pubmed">25156520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SY, Shieh MJ. Platinum(II) Drug-Loaded Gold Nanoshells for Chemo-Photothermal Therapy in Colorectal Cancer. ACS Appl Mater Interfaces. 2020;12:4254&#x2013;4264.</Citation><ArticleIdList><ArticleId IdType="pubmed">31927943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SJ, et al. The synergistic effect of chemo-photothermal therapies in SN-38-loaded gold-nanoshell-based colorectal cancer treatment. Nanomedicine (Lond) 2022;17:23&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">34918941</ArticleId></ArticleIdList></Reference><Reference><Citation>Khlebtsov N, Dykmana L. Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies. Chem Soc Rev. 2011;40:1647&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pubmed">21082078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhwani S, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19:566&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">31932672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozics K, et al. Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles in vivo. Nanomaterials (Basel) 2021;11:1702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8305691</ArticleId><ArticleId IdType="pubmed">34203551</ArticleId></ArticleIdList></Reference><Reference><Citation>Borlan R, Focsan M, Maniu D, Astilean S. Interventional NIR fluorescence imaging of cancer: Review on next generation of dye-loaded protein-based nanoparticles for real-time feedback during cancer surgery. Int J Nanomedicine. 2021;16:2147&#x2013;2171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966856</ArticleId><ArticleId IdType="pubmed">33746512</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng W, et al. Optimal Irreversible Electroporation Combined with Nano-Enabled Immunomodulatory to Boost Systemic Antitumor Immunity. Adv Healthc Mater. 2023 doi: 10.1002/ADHM.202302549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ADHM.202302549</ArticleId><ArticleId IdType="pubmed">38059737</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>